HEAD INJURY

 

          Head injuries are a major cause of morbidity and mortality in the community. Trauma is the third most common cause of death in the United States, exceeded only by cardiocerebral vascular disease and cancer. Trauma is the leading cause of death in youth and early middle age and the death is often associated with major head trauma. Head injury contributes significantly to the outcome in over half of trauma-related deaths. There are approximately 2.5 deaths from head injury per 10 000 population in Australia and neurotrauma causes approximately 3.5% of all deaths. Road traffic accidents are responsible for about 65% of all fatal head injuries in Australia. There is a wide spectrum of head injury from mild concussion to severe brain injury resulting in death. The management of the patient following a head injury requires the identification of the pathological processes that have occurred.

Pathophysiology of head injury

The management of head injury has been based on the concept of primary and secondary brain injury. The primary brain injury was defined as the irreversible pathology sustained at the time of the trauma, whereas the secondary brain injury has been considered the subsequent or progressive brain damage that occurs due to an evolving pathology following the injury. It has been the general contention that the primary injury is irreversible, and management should be directed at preventing or treating secondary pathology (such as cerebral swelling, hydrocephalus and intracerebral haematoma). However, it is now clear that some of the biochemical events associated with what was considered irreversible brain injury are potentially preventable, or even reversible if treatment is instituted early enough. The distinction between primary and secondary injury has become blurred, and the terms, whilst useful concepts, are now becoming obsolete.

Most head injuries result from blunt trauma, as distinct from a penetrating wound of the skull and brain caused by missiles or sharp objects. The pathological processes involved in a head injury are:

direct trauma

cerebral contusion

intracerebral shearing

cerebral swelling (oedema)

intracranial haemorrhage

hydrocephalus.

Direct trauma. Although penetrating injuries produce most of their damage by direct trauma to the brain this is not the case with blunt injuries, in which the energy from the impact has a more widespread effect.

Cerebral contusion. This may occur locally under the position of the impact although it usually occurs more severely at a distance from the area of impact as a result of a ‘contre-coup’ injury. As the brain is mobile within the cranial cavity the sudden acceleration/deceleration force will result in the opposite ‘poles’ of the brain being jammed against the cranial vault. A sudden blow to the back of the head will cause the temporal lobes to slide across the floor of the middle cranial fossa and the frontal lobes across the floor of the anterior cranial fossa, causing contusion on the undersurface of those lobes and to the temporal and frontal poles of the brain as they strike the sphenoid ridge and frontal bones, respectively. Cerebral contusion consists of lacerated haemorrhagic brain, and a ‘burst temporal lobe’ may result when the temporal pole has been severely injured.

Shearing forces. Intracerebral shearing forces occur as a result of the differential brain movement following blunt trauma, frequently in conjunction with a contre-coup type of injury. The rotational acceleration following injury will cause shear forces that result in petechial haemorrhages (particularly in the upper brainstem, cerebrum and corpus callosum), and tearing of axons and myelin sheaths. The early pathological changes consist of retraction balls or microglial scars, and if the patient lives for a number of months before death then widespread degeneration of myelin will be apparent at postmortem.

Cerebral swelling. This occurs following trauma, either in a focal pattern around an intracerebral haematoma or diffusely throughout the cerebrum and/or cerebellum. The nature of the pathological processes are not clearly understood but involve a disturbance of vasomotor tone causing vasodilatation and cerebral oedema. In addition, cerebral contusion and petechial haemorrhages will contribute to the brain swelling.

Intracranial haemorrhage. Intracranial haemorrhage following trauma is discussed in more detail later and may be:

intracerebral

subdural

extradural.

The intracranial haematoma or cerebral swelling may cause the types of cerebral herniation. The medial surface of the hemisphere may be pushed under the falx (subfalcine), the uncus and hippocampal gyrus of the temporal lobe may herniate through the tentorium causing pressure on the 3rd nerve and midbrain (Fig. 4.1), or there may be a caudal displacement of the brainstem and/or cerebellum, herniating into the foramen magnum.

Fig. 4.1 Brain herniations. Alateral supratentorial mass will cause displacement of the lateral ventricles with: (1) subfalcine herniation of the cingulate gyrus below the falx cerebri; (2) herniation of the uncus into the tentorial hiatus; (3) caudal displacement of the brainstem. Raised pressure within the posterior fossa may cause herniation of the cerebellar tonsils into the foramen magnum (4).

 

Hydrocephalus. This occurs infrequently in the early stages after a head injury. It may be due to obstruction of the 4th ventricle by blood, swelling in the posterior fossa, or the result of a traumatic subarachnoid haemorrhage causing obstruction to the absorption of CSF and resulting in a communicating hydrocephalus. This latter type of hydrocephalus is an uncommon, but important, cause of delayed neurological deterioration either in the weeks following the head injury or some years later

 

Concussion

Concussion involves an instantaneous loss of consciousness as a result of trauma. The term ‘concussion’ was introduced by Pare and is derived from the Latin ‘concutere’ which means to shake. In 1941 Denny-Brown and Russell showed that concussion was produced by a blow on the cranium when it was free to move and subsequent studies showed that the acceleration/deceleration of the head resulted in shear strains, contre-coup injury, petechial and punctate haemorrhages throughout the brainstem, cerebral hemispheres and corpus callosum, and neuronal injury, the extent depending on the force of the impact. The term concussion is not strictly defined with respect to the severity of the injury. However, a minimum criterion is that the patient will have had a period of amnesia. The retrograde amnesia of most cerebral concussion is usually short term, lasting less than 1 day. The initial retrograde amnesia may extend over a much longer period but it gradually shrinks down. Amore reliable assessment of the severity of the head injury is the post-traumatic amnesia. If the amnesia following the head injury lasts more than 1 day then the concussion is regarded as being severe.

 

Associated injuries

Cranial nerves

The cranial nerves may be injured as a result of either direct trauma by the skull fracture, movement of the brain, or cerebral swelling.

The olfactory nerves. These are the most commonly affected and this may be as a result of either a fracture through the anterior cranial fossa, directly affecting the tracts, or tearing of the delicate nerve rootlets passing through the cribriform plate caused by the sudden brain movement, particularly from a blow to the back of the head.

The 8th nerve. Damage to this nerve is often associated with a fracture of the petrous temporal bone. Deafness may be conductive, due to a haemotympanum, or sensorineural as a result of injury to the inner ear or to the nerve itself. Vertigo and nystagmus are due to vestibular nerve or end-organ damage and usually resolve within a few months of the injury.

Facial paralysis. This is usually associated with a fracture through the petrous temporal bone, although this may only be evident on a highresolution CT scan using the bone ‘window’. It may be either immediate, as a result of direct compression of the nerve, or delayed, due to bleeding and/or swelling around the nerve.

The 6th cranial nerve. This has a long course from the brainstem to its entry into Dorello’s canal and the nerve is easily damaged by torsion or herniation of the brain.

The 3rd nerve. This may also be damaged by direct trauma or by brain herniation, the herniated uncus of the temporal lobe either impinging on the midbrain or directly stretching the nerve.

The optic nerve. This is infrequently injured by direct trauma.

Skull fractures

Trauma may result in skull fractures which are classified as:

simple—a linear fracture of the vault

• depressed—when the bone fragments are depressed beneath the vault

compound—when there is a direct communication with the external environment. This may result from either a laceration over the fracture or a fracture of the base of the skull which will be compound because there will be a direct connection outside the vault, usually via the air sinuses.

Scalp lacerations

The extent of the scalp laceration does not necessarily indicate the degree of trauma to the underlying brain.

Other injuries

The most common associated injuries are to the chest, skeletal and cardiovascular systems.

 

Initial management of head injury

The key aspects in the management of patients following head injury involve:

accurate clinical assessment of the neurological and other injuries

determination of the pathological process involved

the concept that a change in the neurological signs indicates a progression or change in the pathological processes.

Immediate treatment at the site of the injury involves a rapid restoration and maintenance of an adequate airway, ventilation, essential circulatory resuscitation, first aid treatment of other injuries and the urgent transfer of the patient to hospital. It is essential to avoid hypoxia and hypotension as these will cause further brain injury.

Clinical assessment

It is fundamental to the management of the patient to know of changes in the neurological condition as soon as possible. It is essential to ascertain the type of accident that caused the head injury and the time injury occurred. An accurate assessment of the patient’s initial neurological condition, albeit in non-medical terms, can be obtained from bystanders at the site of the accident or from the ambulance officers.

Neurological examination

An accurate neurological examination will help to determine the type and position of the pathological process and provide a baseline for comparison with subsequent examinations. Although a full neurological examination should be undertaken, special emphasis should be given to the:

conscious state

pupillary size and reaction

focal neurological signs in the limbs.

The conscious state

If the patient will respond verbally an assessment should be made of the retrograde amnesia and post-traumatic amnesia.

There is a continuum of altered consciousness between those patients who are alert and respond appropriately to verbal command and those who are deeply unconscious. The first sign of a depressed conscious state is drowsiness, at which time the patient may be easily arousable and orientated in time, place and person. As the level of consciousness deteriorates the patient will become confused and more drowsy. The term ‘coma’ is generally restricted to patients who show no response to external stimuli, do not obey commands, are unable to utter comprehensible words, and do not open their eyes. However, the use of the words ‘coma’, ‘semicoma’ or ‘stuporose’ should be avoided, as they convey different meanings to different observers. The assessment is more accurate and reproducible if either the exact nature of the response is described or, more simply, the Glasgow coma scale is used.

The Glasgow coma scale (Table 4.1) gives a numerical value to the three most important parameters of the level of consciousness—opening of the eyes, best verbal response and best motor response. The exact response can be represented on a chart (Fig. 4.2) or the level of consciousness given as a numerical score—the sum of the three parameters of the Glasgow coma scale. A score of 8 or less indicates a severe injury.

 

Fig. 4.2 The standard observation chart used at the Royal Melbourne Hospital and at many major trauma centres. The chart incorporates the Glasgow coma scale.

 

Pupillary size and reaction

Careful evaluation of the pupil size and response to light is essential at the initial clinical assessment and during further observation. Raised intracranial pressure causing temporal lobe herniation will cause compression of the 3rd nerve, resulting in pupillary dilatation, which nearly always occurs initially on the side of the raised pressure. The pupil will at first remain reactive to light but subsequently will become sluggish and then fail to respond to light at all. As the intracranial pressure increases this same process commences on the contralateral side. A traumatic mydriasis will also result from direct trauma to the eye, and the dilated pupil should not be confused with that due to a 3rd cranial nerve palsy.

Disorders of ocular movement occur following head injury as a result of injury to an extraocular muscle or its nerve supply, or due to disturbance of the conjugate gaze centres and pathways. A destructive lesion of either a frontal or pontine gaze centre results in tonic overaction of the opposite frontal–pontine pathway for horizontal eye movement, causing ipsilateral deviation of the eyes with a frontal lobe lesion and contralateral gaze deviation with pontine lesions. The oculocephalic manoeuvre and caloric stimulation are important tests of functional activity of the brainstem reticular formation.

The oculocephalic response should only be performed after a cervical spine fracture has been excluded. The head is raised 30° and rotated from side to side in the horizontal plane. In the normal response the eyes maintain their position in space by moving opposite to the rotation of the head. The afferent impulses are from the cervical nerve roots and the semicircular canals.

Caloric testing should also be performed with the head elevated 30° so that the horizontal canals are positioned in the vertical plane. Irrigation with ice-cold water causes ipsilateral tonic gaze deviation.

Skew deviation involves divergence of the eyes in the vertical plane and is a sign of a lesion within the brainstem. Ocular bobbing occurs only after a very severe head injury resulting in pontine damage.

Focal neurological signs in the limbs

Neurological examination of the limbs will assess the tone, power and sensation. A hemiparesis will result from an injury of the corticospinal tract at any point from the motor cortex to the spinal cord. Following a severe brain injury the limbs may adopt an abnormal ‘posturing’ attitude. The decerebrate posture consists of the upper limbs adducted and internally rotated against the trunk, extended at the elbow and flexed at the wrist and fingers, with the lower limbs adducted, extended at the hip and knee with the feet plantar flexed. There is a continuum of severity of brain injury with the decerebrate posturing response being partial and unilateral and occurring only as a result of a painful stimulus to severe continuing bilateral decerebrate rigidity. The posture probably results from an upper brainstem injury. Less frequently, the upper limbs may be flexed, probably due to the injury predominantly involving the cerebral white matter and basal ganglia—corresponding to a posture of decortication.

 

Particular attention must be given to the patient’s ventilation, blood pressure and pulse. At all times it is essential that care is taken to ensure the patient’s ventilation is adequate. Respiratory problems may result either as a direct manifestation of the severity of the head injury or due to an associated chest injury. Cheyne–Stokes breathing is due to either intrinsic brainstem damage or raised intracranial pressure causing pressure and distortion of the brainstem. Bradycardia and hypertension, the Cushing response, are also both indicative of brainstem compression due to raised intracranial pressure.

Pyrexia frequently occurs following a head injury. A temperature lasting for more than 2 days is usually due to traumatic subarachnoid haemorrhage or may occur in patients with a severe brainstem injury.

General examination

Careful assessment must be made of any other injuries. Chest, skeletal, cardiovascular or intraabdominal injury must be diagnosed and the appropriate management instituted. Hypotension or hypoxia may aggravate the brain injury, and, if severe, will themselves cause brain damage.

 

Radiological assessment

Following the clinical evaluation radiological assessment will be essential unless the injury has been minor. The CT scan will show the macroscopic intracranial injury and should be performed where:

there is loss of consciousness (post-traumatic amnesia) of greater than 10 minutes

the patient is persistently drowsy or has a more seriously depressed conscious state

there is persisting nausea or vomiting

there are lateralizing neurological signs

there is neurological or focal deterioration

there is skull fracture

there is CSF rhinorrhoea

there are associated injuries which will entail prolonged ventilation so that ongoing neurological assessment is difficult.

The CT scan will clearly show the presence of intracerebral or extracerebral haematoma, as well as cerebral contusion, oedema and infarction. Small ‘slit’ ventricles and absence of the basal cisterns will indicate generalized brain swelling. The indications for a skull X-ray have diminished since the introduction of the CT scan, especially as the bony vault can be assessed by the CT scan using the bone ‘windows’. If a CT scan has not been performed, a skull X-ray is obligatory if there has been any loss of consciousness or if the mechanism of injury is suggestive of an underlying fracture.

Cerebral angiography is indicated if a caroticocavernous fistula is suspected by the presence of a bruit over the orbit or by pulsating proptosis. Carotid or vertebral angiography will be necessary if arterial dissection is considered a possibility.

NB Full radiological assessment of the cervical spine utilizing plain X-ray and CT scan is essential in patients who have sustained a significant head injury, particularly if there are associated facial injuries.

 

Further management of head injury

Following the clinical and radiological assessment the subsequent management will depend on the intracranial pathology and the extent of any neurological injury.

Minor head injury

The patient would be assessed as described above. Any patient who has suffered a head injury must be observed for at least 4 hours. The following are the minimal criteria for obligatory CT scan and admission to hospital:

loss of consciousness (post-traumatic amnesia) of greater than 10 minutes

persistent drowsiness

focal neurological deficits

skull fracture

• persisting nausea or vomiting after 4 hours’ observation

intracranial pathology noted on a CT scan

if the patient does not have adequate care at home.

The further management of these patients will be careful observation; the neurological observations should be recorded on a chart displaying the features of the Glasgow coma scale. If there has been a period of significant loss of consciousness, or if the patient is drowsy, then the following measures should be instituted to minimize the development of cerebral swelling:

elevation of the head of the bed 20°

mild fluid restriction to 2–2.5 l/day in an adult.

Should the patient’s neurological state deteriorate an immediate CT scan is essential to re-evaluate the intracranial pathology; further treatment will depend on the outcome.

Severe head injury

The management of a patient following a severe head injury depends on the patient’s neurological state and the intracranial pathology resulting from the trauma. In general, the following apply.

1.      The patient has a clinical assessment and CT scan as described previously.

2.      If the CT scan shows an intracranial haematoma causing shift of the underlying brain structures then this should be evacuated immediately.

3.      If there is no surgical lesion, or following the operation, the management consists of:

(a) Careful observation using a chart with the Glasgow coma scale.

(b) Measures to decrease brain swelling; these include:

(i) careful management of the airway to ensure adequate oxygenation and ventilation. Hypercapnia will cause cerebral vasodilatation and so exacerbate brain swelling

(ii) elevation of the head of the bed 20°

(iii) fluid and electrolyte balance. Maintenance of isotonic fluid requirements, avoiding dextrose solutions and following resuscitation should be administered until the patient is able to commence nasogastric feeding. Blood loss from other injuries should be replaced with colloid or blood and not with crystalloid solutions. Care should be taken to avoid overhydration, as this will increase cerebral oedema. Following general injury there is retention of salt and water and excretion of potassium. The retention of water is usually greater than the retention of sodium, resulting in mild hyponatraemia. Following a severe head injury fluid and electrolyte abnormalities may occur for a variety of reasons. Severe hyponatraemia (sodium less than 130 mmol/l) may be due to excessive fluid intake or, occasionally, because of inappropriate excessive secretion of antidiuretic hormone (SIADH). The urine is usually hypertonic with a high sodium level, probably as a result of suppression of aldosterone secretion occurring as a response to overhydration and expansion of the circulating volume.

The term ‘cerebral salt wasting’, which has been applied to this syndrome, is usually inappropriate. Serum sodium of less than 125 mmol/l may produce neurological impairment with depression of conscious state. If due to SIADH the usual treatment is to restrict fluid intake to 800 ml per day or less. Hypernatraemia is usually associated with hyperosmolality and often results from inadequate fluid intake. Other causes are diabetes insipidus, as a result of hypothalamic injury and excessive use of osmotic agents for control of intracranial pressure. Excessive administration of some feeding mixtures may lead to electrolyte abnormalities, particularly when complicated by diarrhoea.

(c) Temperature control—pyrexia may be due to hypothalamic damage or traumatic subarachnoid haemorrhage. However, infection as a cause of the fever must be excluded. The most common sites of infection after a head injury are the respiratory and urinary tracts, particularly if a urinary catheter has been inserted. If the injury is compound, and especially if there has been a CSF leak, intracranial infection should be suspected. The temperature can usually be controlled using tepid sponges, and rectal paracetamol or aspirin. Chlorpromazine, to abolish the shivering response, should be administered if a cooling blanket is required. Every attempt should be made to control the temperature because hyperthermia can elevate the intracranial pressure, will increase brain and body metabolism and will predispose to seizure activity. Although hypothermia has been advocated in the management of a severe head injury no clear-cut benefit has been demonstrated.

(d) Nutrition—during the initial 2–3 days the fluid therapy will include 1.5–2 l of 4–5% dextrose, providing 250–400 calories per day. Proper nutritional support should be commenced after 3–4 days. Feeding at this stage is best done by intragastric administration, usually by a nasogastric tube, unless this is precluded by other injuries. The nasogastric feeding should supply 2500–3000 calories per day with a calorie : nitrogen ratio of 180 : 1. The feeding should commence slowly, with dilute mixtures, and the stomach should be aspirated regularly to prevent regurgitation and pulmonary aspiration.

(e) Routine care of the unconscious patient including bowel, bladder and pressure care.

More aggressive methods to control intracranial pressure are advisable if:

the patient’s neurological state continues to deteriorate and the CT scan shows evidence of cerebral swelling without an intracranial haematoma

there is a posturing (decerebrate) response to stimuli

the Glasgow coma score is less than 8.

In these patients an intracranial pressure monitor should be inserted to assess the intracranial pressure as accurately as possible. A transducer can be placed intraparenchymally via a twist drill craniostomy. A catheter placed into the ventricle will give an accurate reading of the intracranial pressure and CSF can be drained to help in the control of the pressure. However, the disadvantages of an intraventricular catheter include difficulty of placement if the ventricles are small, possible injury to the brain during placement and infection resulting in ventriculitis following prolonged monitoring. A subdural catheter will also give an adequate measurement of the intracranial pressure but may be difficult to insert satisfactorily if the brain is swollen, and will tend to block. Extradural monitors are less accurate, although satisfactory recordings are obtainable with meticulous placement technique.

An intracranial pressure monitor will also be useful in patients requiring prolonged sedation and ventilation as a result of other injuries. Measurement of the intracranial pressure will provide another useful monitoring parameter and any sustained rise in the pressure will be an indication for careful reassessment and, if necessary, CT scan.

Following the insertion of the intracranial pressure monitor the patient will be transferred to the intensive care department. The techniques used to control intracranial pressure are as follows.

• Controlled ventilation, maintaining PaCO2 at 30–35 mmHg. Reduction of the PaCO2 will reduce cerebral vasodilatation and consequently decrease the intracranial pressure.

• If the pressure remains elevated despite hyperventilation CSF can be drained from a ventricular catheter if this has been inserted.

• Diuretic therapy utilizing intermittent administration of mannitol or frusemide (furosemide) can be used if the preceding techniques have failed to control the intracranial pressure. Mannitol is an osmotic diuretic and may also exert its effect by increasing serum osmolality and drawing water out of the brain. The usual dose is 0.5–1.0 g/kg. The serum osmolality should not exceed 320 mosmol/kg.

• Barbiturate therapy can be considered if the intracranial pressure is resistant to treatment with the above techniques. Pentobarbitone (thiopentone) when given as a bolus dose (3–5 mg/kg) is frequently effective in temporarily reducing the intracranial pressure. There is probably little value in using barbiturate infusion at a dose to control burst suppression on EEG, although it has been postulated that this provides brain protection by reducing cerebral metabolism.

• Steroids. Although steroids dramatically reduce the oedema around cerebral tumours they have little effect in controlling the brain swelling following a head injury. Steroid medication is no longer considered advisable as there is no proven benefit for the patient and possible complications, such as gastrointestinal bleeding, poor wound healing and infection, may result from their administration.

• Hypothermia. In some centres hypothermia (to reduce cerebral metabolism and intracranial pressure) has been advocated, with cooling the patient to 34°C. However there is no clear evidence it is beneficial.

• Hyperbaric oxygen has been used in the past, but without proven benefit.

Decompressive craniotomy involving removal of a large area of cranial vault from the frontal and temporal regions bilaterally has been advocated as a means of controlling raised intracranial pressure due to severe cerebral swelling following a head injury. The technique is controversial, but it needs to be performed early following the injury if it is to have a chance of being of benefit to the patient. At present there are no clinical trials proving its efficacy in head injury.

There is some controversy concerning the effectiveness of the more aggressive techniques to treat patients with severe head injuries. If a patient has suffered a profound brain injury and the neurological examination shows little or no remaining brainstem function then it is obvious that the aggressive techniques will provide no benefit and only delay the inevitable. Similarly, there are some patients who have suffered a severe head injury and whose intracranial pressure continues to rise despite all the above techniques.

Other patients will have a fatal brain injury without any substantial rise in intracranial pressure, usually when the brainstem has been the primary site of injury. However, about 30% of patients who have suffered a severe brain injury will obtain substantial benefit from control of the intracranial pressure. Clinical studies have not yet conclusively proven the value of intracranial pressure control in reducing morbidity following a brain injury as it is thought that the patients in the studies that were performed were overventilated and the cerebral blood flow might have been compromised. There is now consensus that a reduction in raised intracranial pressure will not only decrease the mortality but will improve the quality of the patient’s outcome after a severe head injury.

Cerebral perfusion pressure is a vital physiological parameter in the management of severely head injured patients. The cerebral perfusion pressure—mean arterial BP minus mean intracranial pressure—should be maintained above 70 mmHg. Consequently head injury management involves ensuring that the arterial blood pressure is maintained whilst the intracranial pressure is reduced. This often involves close cooperation between the neurosurgeon and the intensive care physician.

 

Management of associated conditions

Scalp injury

Scalp injuries may include:

abrasion

confusion

laceration

subgaleal haematoma.

A large scalp laceration may result in considerable blood loss. When the patient arrives in the emergency department ‘spurting’ arteries should be controlled with haemostatic clips prior to the application of a sterile bandage to the head. The extent of the soft tissue scalp injury may not reflect the severity of the underlying brain injury. The principles of management are similar to those of soft tissue injury at other sites of the body and the wound should be closed without delay. The hair should be shaved widely around the wound, which should be meticulously cleaned and debrided. The closure should be performed in two layers if possible, with careful apposition of the galea prior to closing the skin. The skin sutures should approximate the cut edges of the skin and care should be taken to avoid excessive tension which would cause skin necrosis and wound breakdown.

Straightforward, clean scalp lacerations can nearly always be closed with local anaesthetic infiltration. However, if the scalp wound has resulted in loss of soft tissue the wound may need to be extended to provide an extra ‘flap’ of healthy tissue so that the skin edges can be approximated without tension.

 

Skull fractures

Simple linear fracture. There is no specific management for a simple skull fracture that is undisplaced without an overlying skin injury.

However, the presence of a fracture is an indication that the trauma was not trivial and it should provide a warning that a haematoma may develop beneath the fracture. The patient should be admitted for observation and CT scan performed.

Compound fracture. A skull fracture may be compound either because of an overlying scalp laceration or if it involves an air sinus. The scalp wound should be debrided and closed as described above. A short course of prophylactic antibiotics should be administered to reduce the risk of infection.

Depressed skull fracture (Fig. 4.3). A skull vault fracture is considered to be significantly depressed if the inner table fragments are depressed by at least the thickness of the skull. About half the injuries are due to road trauma and most of the remainder are due either to objects falling on the head at work or to assault with a heavy, blunt instrument. A depressed fracture caused by a non-missile injury usually causes only focal brain damage, so that many patients never lose consciousness. If the underlying injured brain is an eloquent area the patient will exhibit focal neurological signs. Haemorrhage from the bony edges, the dura or underlying brain trauma may result in an intracranial haematoma which will cause progressive neurological deterioration. If the depressed fracture is compound and the dura has been lacerated there is a significantly increased risk of intracranial infection.

Fig. 4.3 Depressed skull fracture.

 

If the depressed skull fracture is compound, prophylactic antibiotics and tetanus prophylaxis should be administered and surgery, usually requiring a general anaesthetic, should be performed as soon as possible. A preoperative CT scan will show not only the position of the depressed skull fragments but also the presence of any underlying intracranial pathology (Figs 4.4 and 4.5). At operation the scalp wound should be cleaned and debrided, as described previously, and the bone fragments elevated. If the dura has been penetrated, or if bone fragments and external foreign material have been driven down into the brain, this must be meticulously debrided and haemostasis obtained. It is desirable that the dura should be closed and this may require the use of a patch of pericranium or fascia lata from the thigh. If the wound and bone fragments are heavily contaminated, and particularly if there has been some delay in surgery, the bone should not be replaced and a reconstructive cranioplasty may be necessary later. If the depressed fracture is closed there is no urgency in elevating the bone fragments, provided there is no underlying intracranial complication. There is controversy over whether a depressed fragment might lead to epilepsy due to continued pressure on the brain. In general, the depressed fragments should be elevated if:

• careful studies using the bone ‘windows’ on the CT scan show that the dura might have been penetrated

there is significant brain compression

the fracture is compound

there are cosmetic considerations such as a frontal fracture in a young child.

Fig. 4.4 Depressed skull fracture with underlying brain contusion.

 

 

 

 

 

 

 

Fig. 4.5  CT showing severe trauma resulting in multiple fractures, disruption of the orbit, intracranial contusions involving the right temporal lobe and intracranial air.

 

The risk of epilepsy following a depressed fracture is 15% for the whole group, but the risk ranges from 3 to 70% depending upon other associated intracranial pathology resulting from the injury. Prophylactic anticonvulsant medication should be continued for 1 year if the dura has been penetrated.

 

Cerebrospinal fluid rhinorrhoea

A fracture involving the base of the anterior cranial fossa may cause tearing of the basal dura resulting in a fistula into the frontal, ethmoid or sphenoid sinuses (Fig. 4.6). This type of fistulous connection should also be suspected if the patient suffers from an episode of meningitis or if the radiological investigations show a fracture in the appropriate site. An intracranial aerocele (Fig. 4.7) is proof of a fistulous connection. CSF rhinorrhoea may also occur as a result of a fistula through the tegmen tympani into the cavity of the middle ear, and may leak via the eustachian tube. Base of skull fractures are relatively frequent as skull fractures are often directed into the skull base by its bony buttresses. They are often occult radiologically but diagnosed clinically. Anterior fossa fractures may open into the frontal, sphenoid or ethmoid sinuses, often running across the cribriform plate. They present with:

subconjunctival haemorrhages extending to the posterior limits of the sclera. Periorbital haematomas or ‘racoon eyes’ indicate subgaleal haemorrhage and not necessarily a base of skull fracture

anosmia

nasal tip paraesthesiae due to anterior ethmoidal nerve injury.

Middle fossa fractures involving the petrous temporal bone present with:

• CSF otorrhoea (or rhinorrhoea) via the eustachian tube

deafness due to 8th nerve injury or ossicular disruption

haemotympanum

Battle’s sign—bruising over mastoid bone

• 7th nerve palsy—often delayed.

Fig. 4.6 Relationship of base of skull to air sinuses.

 

The diagnosis of CSF rhinorrhoea may be difficult. In the early stages following a head injury

involving fractures to the facial bones, CSF needs to be differentiated from a bloody nasal discharge.

Allergic rhinitis is the major differential diagnosis in patients presenting weeks or months after a head injury. Testing for sugar or B2-transferrin in the nasal discharge may help to identify the fluid as being CSF. CSF isotope scans using technetium-99 injected through the lumbar theca are only likely to be positive if there is a large leak. High-resolution CT scanning following the administration of intracisternal contrast may help to identify the position of the hole. The major concern of a dural fistula is the risk of intracranial infection, particularly bacterial meningitis. ACSF leak may not become apparent for a few days after the head injury, but as the brain swelling decreases the dural tear becomes unplugged. Alternatively, CSF leakage may cease due to a brain hernia ‘plugging’ the hole in the dura and bone. Although the brain hernia might stop the CSF escaping it will not provide protection against future intracranial infection, as the dural defect will remain.

There is controversy concerning the indications for an anterior cranial fossa exploration and dural repair, but there is general agreement that surgery should be performed if:

• CSF leakage continues for more than 5 days, indicating the fistula is not trivial

there is an intracranial aerocele

there has been an episode of meningitis in a patient with a fracture of the anterior cranial fossa.

Patients with a possible dural fistula should be placed on prophylactic antibiotic medication. In general, penicillin is recommended as Pneumococcus is the most common organism; amoxycillin is appropriate in children due to the risk of Haemophilus infection. Broad-spectrum antibiotics may lead to the development of resistant organisms and should be avoided. Nasal swabs may indicate the need for more individualized antibiotic prophylaxis.

It is best to delay surgery for about 2 weeks, until the initial brain swelling has resolved. Early surgery, using a craniofacial type of exposure, has been advocated by some neurosurgeons if there are associated major facial and anterior vault fractures. However, early surgery may result in further damage to an already swollen frontal lobe during the retraction necessary to obtain adequate exposure of the dural tear. The operative procedure involves a frontal craniotomy with repair of the dural defect using either pericranium or fascia lata taken from the thigh.

Cerebrospinal fluid otorrhoea

CSF otorrhoea may occur as a result of a base of skull fracture involving the petrous temporal bone. Unlike fractures of the anterior cranial fossa the leakage nearly always settles and the fistula does not usually provide a route of infection, unless there is evidence of chronic middle ear infection. Occasionally, a persistent leak may require surgical exploration and repair.

Fig. 4.7 CT scan showing intracranial air in a subarachnoid space and within the lateral ventricles.

 

Cranial nerve injuries

Injuries to the cranial nerves occurring directly as a result of the trauma are not helped by surgery. Steroid medication is appropriate for patients with a delayed facial nerve palsy following fracture of the petrous temporal bone. Some otologists recommend surgical decompression of the facial nerve when the palsy is delayed but, as the facial function nearly always recovers, operative intervention is usually not justified.

Missile injuries

Although most literature on missile injuries is related to warfare, these injuries are unfortunately becoming more common in civilian conflict, particularly as a result of the increased availability of firearms. In general the cranial injury is directly proportional to the velocity of the missile. The ‘high-velocity’ injury is defined as resulting from a missile travelling faster than the speed of sound (1050 ft/s), and modern rifle bullets have a muzzle velocity greater than 3000 ft/s.

There are three categories of missile injury:

tangential—the missile does not enter the cranium but causes a depressed skull fracture, lacerating the scalp with an underlying cortical contusion, laceration or haematomas

• penetrating—the missile enters the cranium resulting in the deposition of metal, bone fragments and debris within the brain

through-and-through—the missile enters and exits the cranium, frequently creating more than one tract due to fragmentation

The cranial injury is directly related to the velocity of the missile. The energy dissipated by the missile equals MV2 where M is the mass and V the velocity of the missile. Modern ballistics has designed missiles to have maximal velocity and stability in flight with maximal dissipation of energy upon impact. The primary missile frequently fragments and can cause further secondary missiles from fragments of bone or metal.

The missile causes cerebral damage via three mechanisms:

mechanical laceration of brain tissue during transit

the shock wave promulgated ahead of the missile

cavitation in the wake of the missile.

The pathological processes involve scalp injury, depressed skull fracture, intracranial haemorrhage and the intracranial pathological sequelae resulting from a ‘closed’ head injury, including cerebral contusion, haemorrhage, swelling and raised intracranial pressure. The pattern of injury will depend on the velocity of the weapon and the trajectory of the missile through the bone and brain. A high-velocity wound may result in a rapid increase of intracranial pressure of more than 3000 mmHg due to the temporary cavity about the missile, which might be 50 times as large as the missile itself. The high intracranial pressure resulting from the cavitation may result in death from failure of the respiratory and cardiac centres in the brainstem.

Management

Rapid transport of the patient to hospital and urgent treatment is of paramount importance. The early definitive treatment resulting from prompt transport and the introduction of antibiotics were the major factors in lowering mortality from head wounds in the Korean and Vietnam wars. The management of the patient after transfer to hospital is essentially the same as described for severe head injuries previously. Antibiotics should be administered immediately, in large intravenous doses because of the risk of infection; penicillin and chloramphenicol were the most commonly used during the Vietnam conflict. Optimal antibiotic administration should provide a broad cover of Gram-positive, Gram-negative and anaerobic organisms. After neurological assessment, a CT scan should be performed to ascertain the position of the intracranial haematomas, depressed bone fragments and metal fragments. Surgery is not appropriate if the patient is brain dead with no evidence of brainstem reflexes. Patients with less severe injuries should have urgent surgical intervention, particularly as early exploration reduces the risk of subsequent infection.

The operation is performed under general anaesthesia and intravenous diuretic therapy is administered to reduce intracranial pressure. A large scalp flap is designed, with excision and debridement of the entry and exit wounds. Meticulous care is taken to remove any accessible bone or metallic fragments. Haematoma and necrotic brain debris are excised. A watertight dural closure should be performed and the scalp should be closed in two layers (galea and skin). Following surgery, a repeat CT scan will identify any further retained bone or metallic fragments. Accessible fragments should be removed, but isolated deep or inaccessible bone or metallic fragments are probably best left as further neurological damage may occur during an attempt at excision of these particles. In civilian practice, infection is unlikely if exploration has taken place within 2 hours of the injury. In general it is thought that retained metallic fragments have less potential for infection than other debris. Postoperative management is similar to that described for severe head injury, with particular attention to controlling intracranial pressure. Prophylactic antibiotics and anticonvulsant medication are administered.

 

Non-accidental head injury

The infantile chronic subdural haematoma or effusion is a distinct clinical entity. Birth trauma is a frequent cause but in many cases a past history is inadequate to establish the nature of the injury with certainty. Chronic subdural haematomas occur in approximately 20% of battered children. The violent shaking of the immature brain might be sufficient to rupture bridging veins or cause shearing at the grey/white interface without evidence of external trauma. If an inadequate history is provided in such a setting, it is important to screen for a coagulopathy, examine the fundi for retinal haemorrhages, arrange a skeletal survey and when appropriate involve a paediatrician and social services. MRI now plays an important role in determining the chronicity of cerebral injuries in infants. Collections of different chronicity, or in unusual locations, should alert the physician to the possibility of non-accidental injury.

 

Rehabilitation

Some form of rehabilitation is essential following any significant head injury. If the injury has been relatively minor then the necessary rehabilitation may involve only advice and reassurance to the patient and family. However, rehabilitation following a severe head injury will usually involve a team of paramedical personnel, including physiotherapists, occupational therapists, speech therapists and social workers.

The major groups of disabilities resulting from a head injury are:

impairment of motor function—hemiparesis, quadriparesis, ataxia, poor coordination

speech disturbances—dysphasia, dysarthria

impairment of special senses—vision, hearing

cognitive disturbance—memory impairment, intellectual disability, personality change.

The general aims of the rehabilitation process are:

in the initial period, to prevent complications such as contractures of the limbs and to provide counselling for the family

to maximize the neurological recovery by restoring old skills and teaching new skills—this is usually undertaken in a rehabilitation unit

• retraining for future employment, if necessary and if possible.

The rehabilitation process should commence as soon as possible after the head injury and should initially concentrate on preventing complications.

Limb contractures and pressure sores are avoided by frequent patient turning, physiotherapy and the use of splints. As the neurological state improves the patient’s rehabilitation will normally be undertaken in a rehabilitation unit. Orthotic devices will assist hemiplegic patients to walk and, if they can follow simple instructions, most are able to relearn the activities of daily living.

The speech therapist may provide valuable assistance for patients with dysarthria and swallowing difficulties. Formal speech therapy probably does little to improve global aphasia but it does offer important psychological support for the patient with a severe communication disorder.

Damage to the non-dominant hemisphere results in perceptual disturbances, particularly relating to visual spatial tasks. Although the perceptual problems may resolve with time and rehabilitation, the problems associated with cognitive disturbances and alteration of personality may persist. Family counselling and support is essential to help the relatives understand and cope with these long-term disabilities.

Intracranial haematomas

 

Intracranial haematoma formation following head injury is the major cause of fatal injuries in which death may have been potentially avoidable and in which many survivors are unnecessarily disabled following head injury due to a delay in the evacuation of the haematoma. The incidence of intracranial haematomas and the type of haematoma varies widely depending on the different admission policies. In general hospitals that receive an unselected series of patients, the incidence varies between 1 and 5% of all head injuries, while the incidence will be much higher in specialist neurosurgical centres.

Classification of traumatic intracranial haematomas

The general classification depends on the relationship of the haematoma to the dura and brain.

Haematomas can be:

extradural

subdural

intracerebral.

However, many haematomas occupy more than one of the intracranial sites (Table 5.1).

 

 

Extradural haematoma

Extradural haematomas are more likely to occur in the younger age group as the dura is able to strip more readily off the underlying bone. In patients under 20 years of age, extradural haematomas account for about two-thirds of all traumatic intracranial haematomas, but represent less than 5% of haematomas in patients over the age of 50. Although an extradural haematoma may occur in the presence of a severe head injury and coexist with a severe primary brain injury, the important feature of an extradural haematoma is that it may occur when the injury to the underlying brain is either trivial or negligible.

Distribution of extradural haematomas

The most common sites for extradural haematoma are the temporal region followed by the frontal area. Posterior fossa and parasagittal extradural haematomas are relatively uncommon. The relative proportions in a consecutive series of 200 cases from The Royal Melbourne Hospital are shown in Fig. 5.1. In most cases the haemorrhage is from a torn middle meningeal artery or its branches but haematomas may also develop from haemorrhage from extradural veins, the superior sagittal sinus, transverse sinus or posterior meningeal artery, the last two being responsible for the posterior fossa extradural haematomas. A fracture overlies the haematoma in nearly all (95%) adults and most (75%) children.

 

 

 

 

 


Fig. 5.1 Frequency of sites of extradural haematomas in The Royal Melbourne Hospital series of 200 consecutive cases.

Clinical presentation

As previously mentioned, an extradural haematoma may occur as a result of a severe head injury and the haematoma will then become manifest as a further deterioration of the neurological state, particularly with lateralizing features involving a 3rd nerve palsy (dilatation of the pupil) and progressive hemiparesis.

More frequently the extradural haematoma occurs following a head injury that has resulted in only a transient loss of consciousness and in approximately one-quarter of cases there has been no initial loss of consciousness. In these patients the most important symptoms are:

headache

• deteriorating conscious state

focal neurological signs (dilating pupil, hemiparesis)

change in vital signs (hypertension, bradycardia).

Headache. This is the outstanding initial symptom in patients who have not lost consciousness or who have regained consciousness. The headache increases in severity and is followed by vomiting. Deteriorating conscious state. This is the most important neurological sign, particularly when it develops after a ‘lucid’ interval. It is essential that the drowsiness that occurs in a patient following a head injury is not misinterpreted just as the patient wishing to sleep. It is well to remember the nursery rhyme: It’s raining, it’s pouring,

The old man is snoring,

He bumped his head and went to bed,

And couldn’t get up in the morning.

This is a classic description of an extradural haematoma leading to drowsiness and death. Focal neurological signs. These will depend upon the position of the haematoma. In general, a temporal haematoma will produce a progressive contralateral spastic hemiparesis and an ipsilateral dilated pupil. Further progression will result in bilateral spastic limbs, a decerebrate posture and bilaterally dilated pupils (see Chapter 4, Fig. 4.1). Occasionally the hemiparesis may initially be ipsilateral, due to compression of the contralateral crus cerebri of the tentorial edge, but it is rare for the opposite pupil to be involved first.

Change in vital signs. The change in vital signs shows the classic Cushing response to a rise in intracranial pressure—bradycardia accompanied by an increase in blood pressure. Disturbances in respiration will develop into a Cheyne–Stokes pattern of breathing.

Extradural haematomas occurring at other than the temporal position show modifications of this clinical presentation. Frontal haematomas show evidence of lateralizing signs late in their evolution, the predominant features being a deterioration of consciousness and pupil abnormalities. In the posterior fossa the vital signs tend to be affected early, followed by a change in conscious state. The pupils and limbs may not be affected until the patient becomes deeply unconscious.

Haematomas in the posterior fossa may cause sudden respiratory failure.

Radiological investigations

The CT scan is the radiological investigation of choice and must be performed urgently if an extradural haematoma is considered a possibility. The CT scan will show the typical hyperdense (white) biconvex haematoma (Fig. 5.2) with compression of the underlying brain and distortion of the lateral ventricle.

Fig. 5.2 Extradural haematoma with the typical hyperdense biconvex appearance.

 

Treatment

The treatment of extradural haematoma is urgent craniotomy with evacuation of the clot. The patient should have an urgent CT scan as soon as an extradural haematoma is suspected clinically. In some cases the rate of neurological deterioration may be so rapid that there is not sufficient time for a CT scan and the patient should be transferred immediately to the operating theatre. Infusion of mannitol (20% solution, 1 g/kg) or frusemide (20 mg intravenously) may temporarily reduce the intracranial pressure during the transfer to the operating theatre. If unconscious, the patient must be intubated and hyperventilated during the transfer. It is essential that there should be no delay in evacuating the haematoma. An extradural haematoma is a surgical emergency which will result in death if not removed promptly.

Operation for extradural haematoma The type of operation performed will depend on the circumstances in which the patient is being treated.

1 If a CT scan has been performed and the position of the haematoma is known, the skin flap will be lifted directly over the haematoma.

2 If the patient’s neurological state is stable or only slowly progressive and if the surgeon is trained in neurosurgical operations, a formal craniotomy can be performed over the site of the haematoma.

3 A craniectomy, rather than a craniotomy, should be performed:

(a) if the surgeon is inexperienced

(b) if craniotomy instruments are not available

(c) if the rate of neurological deterioration has been so rapid that time has not permitted a CT scan to be performed.

 

Fig. 5.3 Emergency surgery for suspected extradural haematoma. (a) Position of exploratory burr holes. (b) If haematoma found in the temporal position the skin wound is extended. (c) Further bone removed to enable complete evacuation of haematoma and haemostasis.

 

Exploratory burr holes should be inserted first in the temporal region and then in the frontal and parietal areas (Fig. 5.3). When the haematoma is identified the burr hole incision should be extended and the bone over the region of the haematoma should be rapidly removed. If the haematoma is not found on the first side that is explored burr holes should be performed in the same order on the other side. The following are guidelines for the position of the haematoma if a CT scan has not been performed:

(i) it underlies the fracture (that may have been seen on the skull X-ray)

(ii) it underlies a boggy swelling on the skull

(iii) it is on the same side as the pupil that dilated first

(iv) in 85% of cases it is on the contralateral side to the hemiparesis.

Following removal of the bone of the vault by craniotomy or craniectomy it is easy to evacuate the haematoma. The original source of the haematoma, usually the bleeding middle meningeal artery in the temporal haematoma, is controlled by diathermy or with a haemostatic clip. The haematoma will have stripped away the dura from the inner table of the vault, often resulting in considerable oozing from the dural surface. The dura should be opened, if a CT scan has not previously been performed, to exclude the coexistence of a subdural haematoma. It should then be closed in a watertight fashion. It is usually advisable to insert a closed-system, lowpressure extradural drain to evacuate any blood that may continue to ooze. The postoperative care is similar to that for any other intracranial procedure. If the neurological state fails to improve following the evacuation of the haematoma, or if there is further deterioration, another CT scan should be performed to exclude recurrence of the haematoma formation.

Prognosis.

If the initial head injury has resulted in only a transient loss of consciousness, the patient should make a full recovery following removal of the extradural haematoma, provided the haematoma has been evacuated early enough to prevent permanent neurological disability. The damage caused by an extradural haematoma is potentially reversible, provided the haematoma is evacuated before pressure from the blood clot has caused secondary intracranial pathological effects.

 

Subdural haematoma

Subdural haematomas have been classified into acute, subacute and chronic, depending on the time they become clinically evident following injury:

acute subdural haematoma—less than 3 days

subacute subdural haematoma—4–14 days

chronic subdural haematoma—more than 14 days.

The CT scan enables a further classification depending on the density of the haematoma relative to the adjacent brain. An acute subdural haematoma is hyperdense (white) and a chronic subdural haematoma is hypodense. Between the end of the 1st week and the 3rd week the subdural haematoma will be isodense with the adjacent brain.

Acute subdural haematoma

The acute subdural haematoma frequently results from severe trauma to the head and commonly arises from cortical lacerations. However, an acute subdural haematoma can result from a less severe trauma caused by rupture of a bridging vein or focal tear of a cortical artery, especially if the patient has been anticoagulated for other medical reasons (e.g. for atrial fibrillation). Cases of spontaneous acute subdural haematoma have been reported and in these patients it is essential to exclude a ruptured aneurysm or bleeding diathesis as a cause. Acute subdural haematomas are bilateral in approximately one-third of cases, in comparison with less than 3% of extradural haematomas.

An acute subdural haematoma often presents in the context of a patient with a severe head injury whose neurological state is either failing to improve or deteriorating. The features of deteriorating neurological state—decrease in conscious state and/or increase in lateralizing signs— should raise the possibility of a subdural haematoma.

Fig. 5.4 Acute subdural haematoma causing marked shift of the lateral ventricle.

 

The CT scan will show the characteristic hyperdense haematoma, which is concave towards the brain, with compression of the underlying brain and distortion of the lateral ventricles (Fig. 5.4). Over 80% of patients with acute subdural haematomas have a fracture of either the cranial vault or the base of the skull, which may be evident on the bone ‘windows’ of the CT scan.

A craniotomy is nearly always necessary to evacuate an acute subdural haematoma. If the haematoma is liquid the blood can sometimes be washed out with gentle irrigation through burr holes. However if bleeding persists a craniotomy will be required for haemostasis. Chronic subdural haematoma in the adult In 1863, Virchow first proposed chronic inflammation of the meninges as being the cause of a chronic subdural haematoma. In 1914, Trotter suggested trauma as the aetiological factor and in 1932 Gardner, and later Zollinger and Gross, proposed that an osmotic gradient occurred from the breakdown of haemoglobin. However, it was subsequently shown that the osmolarity of the haematoma did not change with time and so this theory was abandoned.

 

Chronic subdural haematoma

can be divided into two major groups. The first involves patients having suffered a significant, and often severe head injury. However, in approximately one third of patients there is no definite history of preceding head trauma. The aetiology of the subdural haematoma in this non-traumatic group is probably related to rupture of a fragile bridging vein in a relatively atrophic ‘mobile’ brain. In this group the majority of patients are over 50 years of age. Shrinkage of the brain resulting from atrophy allows the brain to become more mobile and increases the space traversed by the veins bridging between the cortex and the vault. A relatively trivial injury may result in movement of the brain, like a walnut inside its shell, with tearing of the bridging vein. Patients who are anticoagulated are especially prone to develop a subdural haematoma following relatively minor trauma.

Clinical presentation

The presence of a chronic subdural haematoma should be considered if the neurological state of a patient being treated in hospital for a significant head injury begins to deteriorate. Alternatively, the patient may present without the history of a significant head injury in one of three characteristic ways.

1 Raised intracranial pressure without significant localizing signs. The patient presents with headache, vomiting and drowsiness and the absence of focal neurological signs, raising the differential diagnosis of a cerebral neoplasm or chronic subdural haematoma.

2 Fluctuating drowsiness. The predominant characteristic is a decline in the level of consciousness and the patient may abruptly become deeply unconscious.

3 Aprogressive dementia, which may be misdiagnosed as Alzheimer’s disease. However, the course of the dementia is usually more rapid and progressive. Focal neurological signs may develop, particularly a hemiparesis with an extensor plantar response. In up to 20% of cases the hemiparesis may be ipsilateral to the side of the haematoma due to shift of the brain causing the contralateral crus cerebri to be compressed by the tentorial edge.

A chronic subdural haematoma will be diagnosed on the CT scan as a hypodense, extracerebral

collection causing compression of the underlying, brain (Fig. 5.5). In 25% of cases the haematoma is bilateral (Figs 5.6 and 5.7).

 

 

 

 

 

 

 


The chronic subdural haematoma can be drained through burr holes or a craniotomy located over the haematoma. No attempt should be made to excise all the membrane of the haematoma. As these haematomas may be multiloculated it is advisable to insert more than one burr hole and to visualize the underlying brain at each site.

Fig. 5.5 Chronic subdural haematoma. The fluid is hypodense compared with the adjacent brain.

Fig. 5.6 Bilateral chronic subdural haematoma. The collection on the left is not as hypodense, indicating that it is more recent than the haematoma fluid on the right. It also has a hyperdense area, indicating more recent haemorrhage.

Fig. 5.7 T1 MRI showing bilateral chronic subdural haematoma.

 

The haematoma fluid should be washed out completely and after the operation it is usually advisable to place a subdural catheter for further drainage in a closed drainage system. Following the operation the patient is nursed flat, or even with the head down initially, to encourage the brain to expand into the haematoma space. Careful attention should be given to the fluid intake and serum electrolytes. The normal daily fluid requirements are given (3 l/day in adults) provided there is no clinical or radiological evidence of brain swelling. The patient should be slightly more hydrated after this type of operation than other intracranial procedures, in an attempt to encourage the brain to swell into the previous haematoma space. However, hyponatraemia is a common occurrence, both prior to and following surgery, and if the serum sodium decreases to less than 130 mmol/l the fluid intake should be reduced.

Subdural haematomas in infancy

The infantile chronic subdural haematoma, or effusion, is a distinct clinical entity. Birth trauma is a frequent cause but in many cases a past history is inadequate to establish the nature of the injury with certainty. Chronic subdural haematomas occur in 10% of ‘battered children’ and the violent shaking of an infant may be sufficient to lacerate bridging cerebral veins without evidence of external trauma. Subdural bleeding in infants occurs bilaterally in 85% of cases and is usually over the dorsolateral surfaces of the frontal and parietal lobes.

The earliest finding in infants with chronic subdural haematomas is excessive cranial enlargement as the sutures are unfused. The symptoms are non-specific and usually involve listlessness, irritability and failure to thrive. The diagnosis will be confirmed by CT scan. Treatment initially involves aspiration of the fluid but if, after 2 or 3 weeks, repeated taps have failed to reduce the volume significantly, a shunt may be inserted to drain the fluid from the subdural space to the peritoneal cavity.  

Traumatic intracerebral haematomas

 occur as a result of a penetrating injury (such as a missile injury) or a depressed skull fracture, or following a severe head injury. Intracerebral haematoma is frequently associated with subdural haematoma. The size of the haematoma varies considerably and multiple haematomas are frequently seen on the CT scan following a severe head injury. The contre-coup injury described in may be responsible for a ‘burst’ temporal lobe which results in a large temporal haematoma associated with subdural blood. An intracerebral haematoma should be suspected in any patient with a severe head injury or in a patient whose neurological state is deteriorating.

The CT scan will show the size and position of the haematomas (Fig. 5.8). It should be noted that traumatic intracerebral haematomas not infrequently evolve more than 24 hours after the trauma. Consequently if is essential to repeat a CT scan if the initial scan performed after the injury was negative but the patient’s neurological state deteriorates.

Fig. 5.8 Traumatic frontal intracerebral haematomas resulting from contre-coup injury.

 

A large intracerebral haematoma should be evacuated, unless the patient’s neurological state is improving. Small intracerebral haematomas, particularly if multiple, are not removed but the clinician must be aware that they may expand and require subsequent evacuation.

 

 SPINE TRAUMA

 

Trauma to the spinal column occurs at an incidence  of approximately 2–5 per 100 000 population. Although the majority of spinal injuries do not affect the cord or spinal roots, about 10% will result in quadriplegia or paraplegia. Adolescent and young adult males are the most commonly affected group. Most of the serious spinal cord injuries are a consequence of road traffic accidents (involving cars, motor bikes and bicycles) although there are other major causes of spinal cord injury, for example water sports, especially diving into shallow water, and injuries following skiing and horse riding accidents and drunken falls.

 

Mechanisms of injury

Although severe disruption of the vertebral column usually causes serious neurological damage, it is not always possible to correlate the degree of bone damage with spinal cord injury. Minor vertebral column disruption does not usually cause neurological deficit, but occasionally may be associated with severe neurological injury. The mechanism of injury will determine the type of vertebral injury and neurological damage.

Trauma may damage the spinal cord by direct compression by bone, ligament or disc, haematoma, interruption of the vascular supply and/or traction.

The X-rays taken following a potential spinal cord injury show the vertebral alignment at that time but do not necessarily indicate the amount of disruption that may have occurred at the moment of injury, or the degree of ligamentous damage. In general the injuries can be classified by mechanism of the trauma.

Cervical spine

Flexion and flexion–rotation injuries

This is the most frequent type of injury to the cervical spine; C5/6 is the most common site. Usually, one or both of the posterior facets are subluxed or dislocated and may be locked in this position. There is extensive posterior ligamentous damage and these injuries are usually unstable. The spinal cord may be compressed and distracted, sustaining both direct damage and vascular impairment from involvement of the anastomotic segmental vessels or feeders and secondary compression from subluxation with or without instability

Compression injuries

The vertebral body is decreased in height and there may be a wedge compression fracture or a comminuted fracture with the posterior aspect of the body (retropulsed fragment) encroaching upon the spinal canal. C5/6 is the most common level for this fracture. The wedge fracture injuries are usually stable because the posterior bony elements and longitudinal ligaments are intact. However those with a significant retropulsed fragment are likely to have disruption of the associated ligaments and thus have to be considered unstable. When combined with a rotation force in flexion, a ‘tear drop’ fracture may occur, with separation of a small anteroinferior fragment from the vertebral body, and these should also be considered unstable. Of the patients who do have spinal cord injuries about half have complete neurological deficit below the level of the lesion, the remainder having incomplete deficit with the most damage being to the anterior aspect of the cord.

Hyperextension injuries

These injuries are most common in the older age groups and in patients with degenerative spinal canal stenosis. Bony injury is often not demonstrated and the major damage is to the anterior longitudinal ligament secondary to hyperextension. Most of the injuries result in incomplete cord damage resulting from compression of the cord between the degenerative body and disc anteriorly, and the hypertrophic ligamentum flavum protruding posteriorly. The injuries are nearly always stable and a central cervical cord syndrome is the most common neurological impairment.

Thoracolumbar spine

Flexion–rotation injuries

These injuries occur most frequently at the T12/L1 level and result in anterior dislocation of the T12 on the L1 vertebral body. There is usually disruption of the posterior longitudinal ligament and posterior bony elements. The inferior vertebral body often sustains an anterior superior wedge compression fracture. These are unstable injuries which usually result in complete neurological deficit of either the spinal cord, conus or cauda equina.

Compression injuries

These injuries are common and the vertebral body is decreased in height. They are usually stable injuries and neurological damage is uncommon.

Hyperextension injury

This is a very uncommon mechanism of injury at the thoracolumbar spine. It involves rupture of the anterior longitudinal ligament, rupture of the intervertebral disc and fracture through the involved vertebral body anteriorly. The injuries are unstable and usually cause severe cord injury.

Chance fractures

This injury needs to be considered in patients who are involved in a high-speed accident wearing lap belts without a shoulder harness. They sustain a hyperflexion distraction injury to the thoracolumbar spine. The forward flexion and bending result in two potential types of injuries, and they can cause a fracture through the spinous process pedicle and vertebral body (Fig. 16.2a) or a fracture through the end-plate with disruption of the facet joint and ligamentous structures (Fig. 16.2b). These injuries can easily be missed because of the unusual radiological findings.They could well be associated with internal injuries, especially abdominal injuries.

Fig 1. Mechanisms of injury

Open injuries

These may result from stab injuries or gunshot wounds resulting in cord damage due to the blast injury, vascular damage and/or cord penetration by the missile or bony fragments.

Types of neurological impairment

Immediately after a severe cord injury there is a state of diminished excitability of the isolated spinal cord. This is referred to as ‘spinal shock’ or ‘altered reflex activity’. The transient depression in the segments caudal to the cord lesion is due to sudden withdrawal of a predominantly facilitating or excitatory influence from supraspinal centres. There is an areflexic flaccid paralysis. The duration of spinal shock varies: minimal reflex activity may appear within a period of 3–4 days or may be delayed up to 6–8 weeks, the average duration being 3–4 weeks.

The spinal cord injury is caused by:

• the direct force applied to the cord

• ischaemia due to vascular injury

• secondary haemorrhage in and around the cord.

The degree of neurological injury will be determined by the extent and severity of these mechanisms.

Complete lesions

The most severe consequence of spinal trauma is complete transverse myelopathy, in which all neurological function is absent below the level of the lesion, causing either a paraplegia or quadriplegia, depending on the level. There will also be impairment of autonomic function including bladder and bowel function.

Motor deficit

Injuries to the spinal cord will result in an upper motor neurone paralysis characterized by loss of voluntary function, increased muscle tone and hyperreflexia. Injuries to the lumbar spine causing cauda equina injuries result in lower motor neurone paralysis characterized by reduced muscle tone, wasting and loss of reflexes. Acombination of upper and lower motor neurone lesions results from a thoracolumbar injury involving the conus medullaris and cauda equina.

Sensory deficit

In complete lesions the afferent long tracts carrying the various sensory modalities are interrupted at the level of the lesion, abolishing sensory appreciation of pain, temperature, touch and position and tactile discrimination below the lesion. Visceral sensation is also lost. Sensation may decrease over a few spinal segments before being lost altogether. Occasionally there is a level of abnormally increased sensation, hyperaesthesia and hyperalgesia at or just below the lesion.

Autonomic deficit

Vasomotor control. Cervical and high thoracic lesions above the sympathetic outflow at T5 may cause hypotension. Interruption of the sympathetic splanchnic vasomotor control will initially cause a severe postural hypotension as a result of impaired venous return.

Temperature control. The patient with a complete spinal lesion will not have satisfactory thermal regulation as there will be impairment of the autonomic mechanisms for vasoconstriction and vasodilatation.

Sphincter disturbance

There is impairment of bowel and bladder control; this is discussed later.

Incomplete lesions

Anterior cervical spinal cord

Acute anterior cervical spinal cord syndrome is due to compression of the anterior aspect of the cord. This causes damage to the corticospinal and spinothalamic tracts, with motor paralysis below the level of the lesion and loss of pain, temperature and touch sensation but relative preservation of light touch, proprioception and position sense, which are carried in the posterior columns. The exact pathophysiological process causing this syndrome has not been precisely defined and it may be due either to stretch applied by the attachment of the dentate ligaments at the equatorial plane of the cord or to ischaemic injury from compromise of the anterior spinal artery which supplies the anterior two-thirds of the cord (Fig. 16.3c).

 

Fig. 16.3 (a) Normal cord cross-section. (b) Central cord syndrome. (c) Anterior spinal artery syndrome. (d) Brown-Séquard syndrome. (e) Posterior column syndrome.

 

Central spinal cord

Acute central spinal cord syndrome is usually due to a hyperextension of the cervical spine with compression of the spinal cord between the degenerative intervertebral disc and osteophyte anteriorly and the thickened ligamentum flavum posteriorly. The cord damage is located centrally, with the most severe injury to the more centrally lying cervical tracts which supply the upper limbs. There is disproportionately greater weakness in the upper limbs in comparison to the lower extremities below the level of the injury. Sensory loss is usually minimal, although this is variable and frequently occurs in no specific pattern (Fig. 16.3b).

Brown-Séquard syndrome

The Brown-Séquard syndrome results from hemisection of the spinal cord as from a stab wound, although it infrequently follows a blunt injury. There is ipsilateral paralysis of the limbs below the level of the lesion with loss of pain, temperature and touch on the opposite side of the body. The posterior columns will be interrupted ipsilaterally, but as some fibres cross there is not a great deficit (Fig. 16.3d).

 

 

 

 

 


Spinal cord concussion

There may be a transient loss of function from concussion of the spinal cord. The exact pathological processes involved in spinal cord concussion are not clear but they are probably similar to those occurring in cerebral concussion, resulting in temporary impairment of neuronal function. Recovery usually begins within 6 hours and should be detected within 48 hours.

Management of spinal injuries

As with head injuries, there is little that can be done to repair the damage caused by the initial injury and therefore the major efforts are directed towards prevention of further spinal cord injury and the complications resulting from the neurological damage. The general principles of management are:

• prevention of further injury to the spinal cord

• reduction and stabilization of bony injuries

• prevention of complications resulting from spinal cord injury

• rehabilitation.

Initial treatment

The first aid management of patients with injuries to the spinal column and spinal cord requires the utmost caution in turning and lifting the patient. The spine must be handled with great care to avoid inflicting additional damage. Before moving the patient sufficient help should be available to provide horizontal stability and longitudinal traction. Spinal flexion must be avoided. Atemporary collar should be applied if the injury is to the cervical spine. An assessment should be made for other injuries to the chest, abdomen or limbs.

Hypotension and hypoventilation immediately following an acute traumatic spinal cord injury may not only be life-threatening but may also increase the extent of neurological impairment. Resuscitation techniques may need to be modified to ensure that the spine remains stable. Respiratory insufficiency may require oxygen therapy and ventilatory assistance. Loss of sympathetic tone may result in peripheral vasodilatation with peripheral vascular pooling and hypotension. Treatment will include the use of intravascular volume expanders, alphaadrenergic stimulators, intravenous atropine and occasionally the use of a transvenous pacemaker. There must be careful attention to the body temperature— the spinal patient is poikilothermic and will tend to assume the temperature of the environment. Body temperature must be preserved in cold weather and the patient must not be overheated in warm weather. A nasogastric tube should be passed to avoid problems associated with vomiting due to gastric stasis and paralytic ileus. A urinary catheter should be passed to prevent the complications of bladder overdistension, although intermittent catheterization may become preferable later. Prophylaxis for deep vein thrombosis and subsequent pulmonary embolus should be commenced as soon as possible using low-dose heparin (5000 units subcutaneously twice daily) or low molecular weight heparins. Some centres also favour using various types of compression stockings on the lower limbs.

 

Radiological investigations

Plain cervical spine X-rays and computerized tomography scan will show the bony injuries, and magnetic resonance imaging is very helpful in showing the associated cord, soft tissue and ligamentous pathology (Fig. 16.4). If a cervical spine injury is suspected (in the absence of neurological signs or symptoms) but the plain X-ray and CT scan show no abnormality, the X-rays should be carefully repeated in flexion and extension to exclude instability due to ligamentous damage.

Fig. 16.4 MRI of spinal injury showing the bone damage and cord injury with localized syrinx.

 

Spinal reduction and stabilization

As soon as the systemic parameters have been stabilized, attention should be directed to alignment and stabilization of the spine. The use of skeletal traction for the restoration and/or maintenance of the normal alignment of the spinal column is a time-honoured and effective treatment. There are various types of cervical traction devices. The spring-loaded tongs have become popular because of their ease of application and maintenance. The usual practice is to apply weight to the traction device to a maximum of 5 lb or 2.25 kg for each level below the occiput (e.g. C6 = 30 lb or 13.5 kg). It is usual to commence with half the maximum weight and, under X-ray or fluoroscopic control, gradually add weights up to the maximum if necessary. These patients will require analgesia. Their body weight is utilized for counter traction by tilting the entire bed in a head-up position. It is important to maintain a neutral spine. Extreme care should be taken to avoid distraction at the fracture site as the traction on the underlying cord may worsen the neurological injury. Reduction of  facet dislocations may be more difficult and require more weight for the traction. Some advocate manipulation of the neck under fluoroscopic control while weight is being applied to accomplish reduction of locked facets. In Australia and Europe cervical traction under general anaesthesia has been used for closed reduction of some fracture dislocations but this has not been popular in the United States. Open surgery may be necessary to reduce the fracture—subluxation with overriding and locked facet joints. Following reduction the position may be maintained with skeletal traction or halo immobilization.

Injuries of the thoracolumbar spine can usually be managed conservatively by postural reduction in bed. The correct posture must be maintained during positioning on the side, as well as on the back; this is achieved by the appropriate placement of bolsters and pillows by a turning team.

Indications for surgical intervention

There has been considerable controversy over surgical intervention in patients with spinal cord injuries. The damage to the spinal cord occurs principally at the time of the injury and it is not surprising that there has been no evidence to show improved neurological function from acute operative decompression of the spine. The following are the general indications for surgical intervention.

1 Progression of neurological deficit is an absolute indication. It requires emergency intervention if a compressive lesion is demonstrated by either MRI or CT scan.

2 Patients who have a partial neurological injury, with preservation of some distal neurological function, and who fail to improve should have further radiological assessment. Surgery should be considered if this shows persisting extrinsic compression of the spinal cord within the canal (particularly from a herniated cervical disc), a depressed fractured lamina or an osteophytic bar, although removal of the compression may not result in any neurological improvement.

3 An open injury from a gunshot or stab wound should be explored to remove foreign particles, elevate bone spicules and, if possible, repair the dura.

4 The most common indication for operative intervention is to stabilize the spine. This is usually undertaken:

(a) if there is gross instability, particularly in the presence of an incomplete neurological lesion

(b) if it has not been possible to reduce locked facets by closed reduction—posterior reduction and fusion is appropriate

(c) if operative procedures are needed to stabilize the unstable cervical spine and so avoid prolonged bed rest; these are favoured by many spinal injury units (Fig. 16.6).

Other treatments for spinal cord injury

Numerous pharmacological agents have been investigated in experimental laboratory models but as yet there has been no controlled clinical study to show the usefulness of these agents in spinal cord injury. The reatments include glucocorticoids, diuretics, local hypothermia, barbiturates and endogenous opiate agonists. Although there is no proven benefit, some spinal units use glucocorticoids and osmotic diuretics for the treatment of oedema. The early use of high-dose dexamethasone may be beneficial, but there is no conclusive proof.

Fig. 16.6 Postoperative X-ray—anterior cervical discectomy and bone and plate fusion.

 

Further management

Following reduction and immobilization of the fractures the principles of the continuing care involve the avoidance of potential complications in patients who are paraplegic or quadriplegic, and early rehabilitation, which commences as soon as the injury is stabilized.

General care

Careful attention to the general condition and metabolic state is essential following the injury; patients frequently develop a negative nitrogen balance and may become anaemic. Urinary tract or other infections will aggravate the metabolic disorders. The patients and their relatives will require skilled counselling and emotional support during the treatment and rehabilitation period.

Skin care

Meticulous attention to pressure areas will avoid the development of pressure sores which would seriously complicate the recovery and rehabilitation of the patient.

Gastrointestinal complications

Paralytic ileus occurs in acute spinal cord paralysis and if this is unrecognized, the patient is at risk from vomiting and aspirations. Anasogastric tube should be passed in the initial management of the patient. Acute gastric dilatation may also develop and is also treated by nasogastric suction. In 3–5% of patients with acute spinal cord injuries acute peptic ulceration occurs.

Bladder care

Urinary tract problems are a major cause of potential morbidity and mortality. During the period of spinal shock the areflexic, flaccid paralysis below the level of the lesion includes bladder function. The patient will develop acute retention with overflow incontinence and a catheter is required. Reflex activity returns in upper motor neurone lesions as the phase of spinal shock passes. The spinal micturitional reflex arc is intact in a

lesion above the conus and an autonomic type of bladder results. The bladder will empty involuntarily as it fills with urine. The capacity may be less than normal, but there is good voiding pressure capacity. There is no sensation of bladder fullness. In a lower motor neurone lesion the spinal micturitional reflex is interrupted and an autonomous bladder results. Bladder function is governed by a myogenic stretch reflex inherent in the detrusor fibres themselves. This type of dysfunction is characterized by a linear increase in intravesical pressure, with filling until capacity is reached. Urine may then flow past the sphincter by overflow incontinence. In a mixed upper and lower motor neurone lesion, such as with a conus medullaris and cauda equina injury, it is possible to have a flaccid lower motor neurone detrusor and a spastic sphincter, as well as the reverse. The principles of management of the bladder consist of maintaining proper bladder drainage to prevent dilatation of the upper urinary tract and renal impairment, and the treatment of urinary tract infections. Acatheter is passed initiallyand bladder training is commenced after the period of spinal shock. The details of bladder training and management depend on whether the neurogenic bladder has resulted from an upper or a lower motor neurone lesion and on the results of a cystometrogram showing the intravesical volume pressure relationship.

Limb care

It is essential that the paralysed limbs should be put through their full range of movements regularly. Physiotherapy, in particular, is essential to prevent contractures as the tone returns and spasticity develops.

Special cervical spine injuries

Jefferson’s fracture

Jefferson described bilateral fractures of the posterior arch of the atlas from a direct vertical blow to the head in four patients. The mechanism of the fracture is due to the head pressing down on the spinal column and the atlas being squeezed between the occipital condyles above and the axis below. The grooves for the vertebral artery are the sites where the arches of the atlas are weakest, and when fractures occur at this site bursting fragments are displaced outwards.

Fractures of the odontoid process

A fracture of the odontoid process may occur at the tip (type I) through the base of the dens (type II) or at the base and extend into the adjacent C2 vertebral body (type III). The fractures that occur at the base of the dens are the most common and may cause disruption of the blood supply to the dens, resulting in non-union of the fracture (Fig. 16.7).

Many of the odontoid fractures can be treated by immobilization in a firm brace or halo for 4 months. If there is non-union and instability a posterior C1/2 fusion will be necessary. Anterior screw internal fixation of the odontoid fracture has been advocated but is indicated in certain situations.

Fig. 16.7 Fractures of the odontoid process.

 

Hangman’s fracture

This fracture is the avulsion of the laminar arches of C2 with dislocation of the C2 vertebral body on C3. It is the characteristic lesion resulting from judicial hanging.

 

Outcome following spinal cord and roots injury is summarized:

MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS

 

Brain tumours are responsible for approximately 2% of all cancer deaths. Central nervous system tumours comprise the most common group of solid tumours in young patients, accounting for 20% of all paediatric neoplasms. The overall incidence of brain tumours is 8–10 per 100 000 population per year. The incidence increases after the 4th decade of life to reach a maximum of 16 per 100 000 per year in the 7th decade.         

Aetiology 

 

 

 


Epidemiology studies have not indicated any particular factor (viral, chemical or traumatic) that causes brain tumours in humans, although a range of cerebral tumours can be induced in animals experimentally. There is no genetic predisposition but chromosome abnormalities have been noted in many CNS tumours  

There is no specific evidence linking CNS tumours to environmental carcinogens, although many chemicals, especially ethyl and methyl nitrosourea and anthracene derivatives, show carcinogenic activity in animals and produce CNS tumours. Viral induction of brain tumours has been used in animal models but there is no firm evidence for viral aetiology in humans. Ahuman polyoma JC virus injected into primates produces tumours similar to human astrocytomas after an 18-month incubation period. This type of ‘slow virus’ effect may account for some of the problems of isolating viruses from human tumours.

Although immunosuppression is known to increase markedly the risk of primary lymphoma of the brain, particularly in transplant recipients, there is not the corresponding increased incidence of gliomas.

At present there is considerable conjecture regarding the role of other possible aetiological agents, including trauma, electromagnetic radiation and organic solvents but, as yet, there is no convincing evidence to implicate these as being involved with the development of brain tumours in humans.

The four hallmarks of the development of a cancer cell are the ability to proliferate, with the intracellular growth pathways constituitively activated, the evasion of apoptosis, with the cancer cells having escaped from cell death pathways, the attraction and induction of new blood vessels(angiogenesis) to supply increased metabolic activity of tumour cells, and tissue invasion. Each of these are dependent on ligand–receptor interactions on the cell surface leading to a cascade of cytoplasmic events that eventually result in differential gene expression.

Molecular biology techniques have enabled the identification of a variety of alterations in the genome of the tumour cell, including those of brain tumours. The present concept of oncogenesis involves both the addition of oncogenes to the genome and the loss of the normally occurring tumour suppressor genes. Transformation (spontaneous or induced) is a multistep process requiring both initiation and promotion. Oncogenes encode proteins that participate in the signal transduction and second messenger systems that modulate cell metabolism and proliferation. These proteins include both growth factors and growth factor receptors such as epidermal growth factor receptor, platelet-derived growth factor, tryosine-specific protein kinases and guanine-binding proteins.

Tumour suppressor genes are normally present in the genome and act as a ‘brake’ on cell transformation. Mutations in the p53 tumour suppressor gene on chromosome 17 are the most common gene alteration found to date in tumours and have been shown to occur in both astrocytomas and meningiomas. The Li–Fraumeni syndrome is due to a germ line mutation in the

p53 gene with the development of numerous cancers including gliomas, ependymomas and medulloblastomas.

 

Glioma

Neuroectodermal tumours arise from cells derived from neuroectodermal origin. Gliomas comprise the majority of cerebral tumours and arise from the neuroglial cells. There are four distinct types of glial cells: astrocytes, oligodendroglia, ependymal cells and neuroglial precursors. Each of these gives rise to tumours with different biological and anatomical characteristics. The neuroepithelial origin of microglia is in question.

The most common gliomas arise from the astrocytecells which The tumours arising from astrocytes range from the relatively benign to the highly malignant. The term ‘malignant’ for brain tumours differs from its usage for systemic tumours. Intrinsic brain tumours very rarely metastasize (except for medulloblastoma and ependymoma), and ‘malignant’ refers to aggressive biological characteristics and a poor prognosis.

 

Classification

There are many classification systems of brain tumours in general and gliomas in particular. The period of systematic classification of tumours began in 1846, when Virchow described the neuroglia and related it to brain tumours. Although Virchow created the term ‘glioma’, these tumours had already been described under other names. In 1926, Bailey and Cushing described a histogenetic classification system which compared the predominant cell in the tumours with the embryonal development of the neuroglia. The comparison with stages of cytogenesis was probably more of a working hypothesis than an oncological theory for the origin of the tumours’ cells. The theory that gliomas originate from proliferation of cells of varying degrees of maturity lying dormant in the brain is not generally accepted except in the case of medulloblastoma, which may arise from a primitive layer in the cerebellar cortex.

A valuable prognostic system of subclassification of astrocytoma was described by Kernohan in 1949. Astrocytomas were graded from I to IV, with Grade IV being the most malignant and Grade I cytologically, but not necessarily biologically, benign. Ringertz simplified the four-grade classification of Kernohan into a three-tiered system; the comparison between the two is shown in Fig. 1. The glioblastoma multiforme, equivalent to the Kernohan Grade III and IV tumours, is the most common adult cerebral tumour, accounting for approximately half of all gliomas. The low-grade gliomas—the astrocytoma, or Grade I or II Kernohan astrocytoma—account for only 10–15% of astrocytomas.

The World Health Organization (WHO) classification recognizes four grades of astrocytoma. Grade I is assigned to the pilocytic astrocytoma which is biologically distinct from the diffuse astrocytomas, which are classified as astrocytoma (WHO Grade II), anaplastic astrocytoma (WHO Grade III) and glioblastoma multiforme (WHO Grade IV).

A grading system proposed by Daumas-Duport and also known as the St Anne–Mayo System assessed the tumours according to the presence or absence of four morphological features— nuclear atypia, mitosis, endothelial proliferation, and necrosis—and they are graded according to the cumulative features score. Grade I tumours have none of the features, Grade II tumours have one feature, Grade III tumours have two features and Grade IV tumours have three or four features.

Pathology

Macroscopic changes

An astrocytoma may arise in any part of the brain, although it usually occurs in the cerebrum in adults and the cerebellum in children. A low-grade tumour in the cerebral hemispheres invades diffusely into the brain. The tumour does not have a capsule and there is no distinct tumour margin. The low-grade gliomas are usually relatively avascular with a firm fibrous or rubbery consistency. Fine deposits of calcium are present in 15% of astrocytomas. Occasionally, a low-grade astrocytoma may invade diffusely throughout the cerebral hemisphere. In contrast, the macroscopic appearance of a highgrade tumour, the glioblastoma multiforme, is characterized by a highly vascular tumour margin with necrosis in the centre of the tumour. Although in certain areas the margin of the tumour may seem to be macroscopically well defined from the surrounding brain, there are microscopic nests of tumour cells extending well out into the brain.

Microscopic changes

The histological appearance of the tumour varies with the tumour’s grade. The low-grade astrocytoma is characterized by an increased cellularity, composed entirely of astrocytes. Intermediate-grade tumours show nuclear pleomorphism, mitotic figures are frequent, and there is increased vascularity, as evidenced by endothelial and adventitial cell proliferation. In the high-grade astrocytoma very few astrocytes appear normal. There is marked cellular pleomorphism, extensive endothelial and adventitial cell proliferation and numerous mitotic figures with extensive necrosis. The major histological features of glioblastoma multiforme are endothelial proliferation and necrosis. The anaplastic astrocytoma is characterized by nuclear pleomorphism and mitoses, which are absent in the astrocytoma.

 

Clinical presentation

The presenting features can be classified under:

• raised intracranial pressure

• focal neurological signs

• epilepsy.

The duration of the symptoms and the progression and evolution of the clinical presentation will depend on the grade of the tumour—that is, its rate of growth. Apatient presenting with a low-grade astrocytoma (Grade I or II) may have a history of seizures extending over many years, antedating the development of progressive neurological signs and raised intracranial pressure. The tumours may evolve histologically into the more malignant anaplastic astrocytoma or glioblastoma multiforme. Patients with the higher-grade tumours present with a shorter history and glioblastoma multiforme is characterized by a short illness of weeks or a few months.

Raised intracranial pressure is due to the tumour mass, surrounding cerebral oedema and hydrocephalus due to blockage of the CSF pathways. The major symptoms are headache, nausea and vomiting, and drowsiness.

Headache is the most common symptom in patients with cerebral astrocytoma and occurs in nearly three-quarters of patients; vomiting occurs in about one-third. The headaches are usually gradually progressive and although frequently worse on the side of the tumours, theymay be bitemporal and diffuse. Characteristically, the headache is worse on waking and improves during the day. Nausea and vomiting occur as the intracranial pressure increases, and the patient frequently indicates that vomiting may temporarily relieve the severe headache. Drowsiness, that is, a deterioration of conscious state, is the most important symptom and sign of raised intracranial pressure. The extent of impairment of conscious state will be related to the severity of raised intracranial pressure. An alert patient with severely raised intracranial pressure may rapidly deteriorate and become deeply unconscious when there is only a very small further rise in the pressure within the cranial cavity.

Focal neurological deficits are common in patients presenting with cerebral gliomas; the nature of the deficit will depend on the position of the tumour. Patients presenting with tumours involving the frontal lobes frequently have pseudopsychiatric problems, personality change and mood disturbance. These changes are particularly characteristic of the ‘butterfly glioma’, so called because it involves both frontal lobes by spreading across the corpus callosum, giving it a characteristic macroscopic (Fig. 4) and CT or MRI appearance. This type of tumour may also occur posteriorly, with spread across the splenium of the corpus callosum into both parieto-occipital lobes. Limb paresis results from interference with the pyramidal tracts, at either a cortical or a subcortical level, and occurs in just under 50% of patients.  Field defects associated with tumours of the temporal, occipital and parietal lobes are common, but may be evident only on careful testing. Dysphasia, either expressive or receptive, is a particularly distressing symptom occurring in patients with tumours involving the relevant areas of the dominant hemisphere. The particular characteristics of posterior fossa and brainstem gliomas will be discussed in the following section on paediatric tumours.

Epileptic seizures are the most frequent initial symptom in patients with cerebral astrocytoma and occur in 50–75% of all patients. Tumours adjacent to the cortex are more likely to be associated with epilepsy than those deep to the cortex and tumours involving the occipital lobe are less likely to cause epilepsy than those which are more anteriorly placed. Astrocytomas may produce either generalized or focal seizures; the focal characteristics will depend on the position within the brain and the cortical structures involved.

Investigations

Computerized tomography

CT scan or MRI of the brain are the essential radiological investigations (Figs 5 and 6); an accurate diagnosis can be made in nearly all tumours. Low-grade gliomas show decreased density on the CT scan; this does not enhance with contrast and there is little or no surrounding oedema. Calcification may be present. High-grade gliomas are usually large and enhance vividly following intravenous injection of contrast material (Fig. 7). The enhancement is often patchy and nonuniform and frequently occurs in a broad, irregular rim around a central area of lower density. Although tumour cysts may occur in the highgrade tumours, the central area of low density surrounded by the contrast enhancement is usually due to tumour necrosis. High-grade tumours are surrounded by marked cerebral oedema and there is frequently considerable distortion of the lateral ventricles. Compression of the lateral ventricle in one hemisphere, with pressure extending across the midline, may result in an obstructive hydrocephalus involving the opposite lateral ventricle.

Magnetic resonance imaging

When used with gadolinium contrast enhancement, MRI improves the visualization and anatomical localization of the tumours (Figs 8 and 9). MRI has the advantage of being more sensitive than CT scan, enabling the detection of small tumours and particularly low-grade gliomas that might be missed by CT scan. MRI provides better anatomical detail and is more useful in visualizing skull base, posterior fossa and brainstem tumours.

Low-grade astrocytomas may show up on MRI as abnormal areas of increased T2 signal and decreased T1 signal, even if the CT scan was normal. High-grade astrocytomas characteristically have low signal intensity on T1-weighted images and high signal intensity on T2-weighted images. Gadolinium enhancement is more likely to occur in the higher-grade tumour.

Perfusion-weighted MRI is used to determine the regional cerebral blood volume, which is increased in high-grade glioma and may be of value in differentiating recurrent tumour from radiation necrosis. Magnetic resonance spectroscopy (MRS) is a non-invasive technique that provides information on the composition and spatial distribution of cellular metabolites. On proton MRS, tumours have an increased lactate production, loss of N-acetyl aspartate (due to loss of neurones in the tumour area) and increased choline levels (due to active membrane biosynthesis).

http://www.neurochirurgia-ire.it/fig/fig4-1.jpg

Fig. 5 Low-grade astrocytoma.

http://www.ukb.uni-bonn.de/42256BC8002B7FC1/vwLookupImagesforLoad/Tumor1.jpg/$FILE/Tumor1.jpg

Fig. 6 MRI showing low-grade glioma

http://img.medscape.com/pi/emed/ckb/radiology/336139-340870-8133.jpg

Fig. 7 Glioblastoma multiforme

Cerebral angiography

This was the standard study in most patients with astrocytomas prior to the introduction of CT. It provides helpful information on the vascular supply of the tumours but is now only rarely indicated.

Plain X-rays

Plain X-rays of the skull do not need to be performed as a routine. The most common abnormality is erosion of the sella turcica due to long-standing raised intracranial pressure. Radiologically visible calcification is present in about 8% of patients with astrocyte-derived gliomas.

 

Management

Following the presumptive diagnosis of a glioma the management involves:

• surgery

• radiotherapy

• other adjuvant treatments.

Surgery

Surgery is performed with three principal aims.

• To make a definite diagnosis.

• Tumour reduction to alleviate the symptoms of raised intracranial pressure.

• Reduction of tumour mass as a precursor to adjuvant treatments.

The patient is started on glucocorticoid steroid therapy (e.g. dexamethasone) when presenting with clinical features of raised intracranial pressure with the aim of decreasing the cerebral oedema prior to surgery.

The type of operation performed will largely be determined by the position of the tumour and by the patient’s clinical presentation. In general, the tumour is excised as radically as possible, provided the surgery will not result in any disabling neurological deficit. Craniotomy is performed in the position that provides the best access to the tumour and usually with the aid of a frameless stereotactic system to aid accuracy of localization. If the tumour has not grown to involve the cortical surface, a small incision is made in a non-eloquent gyrus or sulcus and the subcortical brain is divided down to the tumour mass.The tumour is excised, often with the aid of an ultrasonic aspirator. Occasionally, the tumour may involve one of the ‘poles’ of the hemisphere and the excision may entail a partial lobectomy.

Although a craniotomy with radical tumour excision will alleviate the symptoms of raised intracranial pressure, there has been controversy as to whether a radical resection improves survival. Most high-grade gliomas weigh approximately 100 g at the time of diagnosis and consist of 1011 cells. A radical tumour excision is able to excise the macroscopic tumour but cannot remove the tumour cells that are infiltrating deep into the adjacent, often vital, areas of normal or oedematous brain. Consequently, a radical excision is unlikely to achieve more than a 90–95% reduction in tumour cell numbers, resulting in 1010 cells remaining. Whether the 1–2 logs of tumour cell reduction are a significant reduction in tumour burden prior to adjuvant therapy and whether it improves the effectiveness of subsequent treatment is still not completely resolved, although recent clinical studies do seem to show a survival benefit following tumour resection and this is favoured by most neurosurgeons provided the tumour excision can be performed without causing significant neurological mortality.

Alternatively, a biopsy, which can be performed most accurately using stereotactic methods, may be undertaken to obtain the definite histological diagnosis, without macroscopic tumour excision, if:

• the tumour is small and deep seated

• the tumour is diffuse, without major features of raised intracranial pressure, and macroscopic resection is not feasible

• the tumour involves highly eloquent areas (e.g. speech centre) without pronounced features of raised intracranial pressure.

Stereotactic biopsy involves localization of the tumour with a stereotactic frame applied to the head of the patient using the CT scan or MRI. The three-dimensional coordinates of the tumour are ascertained. The surgeon chooses the point of entry and the desired path through the brain and a computer program determines the necessary angles for the biopsy probe and the depth to the tumour (Fig. 6.10). 

Postoperative care

The postoperative management of astrocytoma involves the routine care of a patient following a craniotomy. Careful neurological observations are performed, as prompt intervention is essential if the patient’s neurological state deteriorates as a result of either increasing cerebral oedema or postoperative haemorrhage. A postoperative haematoma may occur in the region of the tumour excision or it may be extracerebral, either subdural or extradural. A CT scan should be performed urgently if there is neurological deterioration, to determine the exact pathology. Occasionally, postoperative deterioration may be so rapid as to require urgent re-exploration of the craniotomy without prior radiological assessment.

In the initial postoperative period it is essential to avoid overhydration of the patient so as not to precipitate cerebral oedema. The patient isnursed with the head of the bed elevated 20°, so as to promote venous return and reduce intracranial venous pressure. Steroid medication is usually required in the initial postoperative period and is gradually decreased over the following days. The steroids may need to be re-instituted during the course of radiotherapy. The patient is usually mobilized as soon as possible, if necessary with the help of a physiotherapist.

Radiation therapy

Postoperative radiation therapy is generally an effective adjunct to surgery in the treatment of higher-grade gliomas. It has been shown to double the median survival for high-grade gliomas to 37 weeks. Radiation treatment is planned to optimize the homogeneity of the radiation dose throughout the tumour volume selected and to minimize high dose regions in normal brain transited by the radiation beam. The size of the daily radiation fraction is related to the incidence of complications and a maximal daily dose is usually between 1.8 and 2.0 gray. The total radiation dose varies depending on the tumour type, location and size of field, but for gliomas it is usually between 45 and 60 gray. Opinion varies regarding the tissue volume that should be treated for malignant glioma but radiation to the tumour area and a ‘generous volume’ of surrounding brain is now advocated, rather than radiation to the whole brain. The selection of the proper radiation dose for gliomas is as controversial. Although increasing the radiation dosage from 50 to 65 gray does slightly improve survival, the higher dose of radiation therapy, especially over 65 gray, significantly increases the risk of brain necrosis.

Prognosis

At present there is no satisfactory treatment for the malignant cerebral glioma—the anaplastic astrocytoma and glioblastoma multiforme. The median survival following surgery is approximately 17 weeks and when radiation therapy is used as an adjuvant the median survival is approximately 37 weeks. Chemotherapy for highgrade gliomas has been disappointing and the best results with surgery, radiation therapy and chemotherapy consistently show a median survival time of less than 1 year. The median normal for the low-grade glioma (fibrillary astrocytoma; WHO Grade II, Daumus–Duport Grades I and II) is approximately 8 years, with most tumours progressing to a higher grade.

The role of surgery, radiation therapy and other adjuvant therapies in low-grade gliomas is even less certain than for the high-grade glioma. The low-grade tumour may remain relatively quiescent for some years before it either continues to grow slowly or changes to a more anaplastic tumour with resulting debilitating neurological deterioration. In general, the same principles for surgical excision apply for lowgrade gliomas as for high-grade gliomas. However, a number of clinical studies have shown that patients having a radical excision of a tumour have a longer 5-year survival than those with a subtotal excision. Radiation therapy has not been shown to improve the survival in patients with low-grade tumours. In general, other adjuvant therapies are not used for the treatment of low-grade astrocytoma, but may be of benefit for oligodendrogliomas.

Other adjuvant therapies

Many different adjuvant therapies have been investigated for the treatment of glioma. These include the use of new chemotherapeutic agents, new methods of administering cytotoxic chemicals, immunotherapy, hyperthermia, new techniques of radiotherapy, photodynamic therapy, and gene therapy.

The lack of effectiveness of the present treatment of gliomas is related to the biology of the tumour. The most common position for tumour recurrence following conventional treatment is locally, in the tumour bed, indicating that treatment has failed in local control. Although light microscopy shows high-grade gliomas to have a relatively well-defined border with the adjacent brain, special staining techniques, including monoclonal antibodies, show malignant cells extending well out into the surrounding brain. It is the failure to control the growth of these cells that is largely responsible for the local tumour recurrence. As indicated previously, a good surgical resection with 90% of the tumour excised would still result in 1010 cells being present. Effective radiotherapy will result in 1 log (90%) or at the most 2 logs (99%) of cell kill and it is unlikely that subsequent chemotherapy would reduce remaining tumour cells by more than 90%. Consequently, the effect of cytoreductive surgery, radiotherapy and chemotherapy would result in approximately 108 cells remaining; the immune system is unlikely to be able to cope with a tumour burden of more than 105 cells. It follows that, for any extra treatment to be effective, whether surgery or adjuvant therapy, it must provide at least 1 log of cell kill.

Chemotherapy

Conventional chemotherapy has been disappointing. Many of the chemotherapy agents that are active in vitro, or in other systemic tumours, have reduced activity in malignant brain tumours, either by exerting an inherently limited cytotoxic potential on brain tumour cells or by the inability of the chemotherapeutic agent to reach the cells that are responsible for the tumour recurrence. A study of brain tumour cell kinetics of high-grade gliomas shows only a small proportion of the cells (5–10%) in an active growth phase; this has serious consequences for any cell cycle-specific cytotoxic agent. Until recently the most commonly used single agent cytotoxic regime involves administration of nitrosourea compounds. The high lipid solubility and low ionization of these agents ensures a relatively effective penetration of the cytotoxic compound into the tumour. Combination therapy, utilizing many different cytotoxic compounds, has been used in various trials but none of the combinations has been shown to be more beneficial than the use of the single nitrosourea.

Temozolomide is an alkylating agent that can be taken orally, penetrates the CNS and is well tolerated with predictable myelotoxicity. Clinical studies have shown it to be effective in about 40% of patients. It is now the initial chemotherapy agent of choice, but it is usually used at the time of tumour recurrence, rather than as an adjuvant to surgery.

It has been postulated that a reason for the lack of effectiveness of chemotherapy is the inability of the cytotoxic compound to reach the tumour cells which are invading the normal adjacent brain. This has resulted in new techniques of delivering the cytotoxic agent. High-dose chemotherapy with bone marrow rescue has largely been abandoned because of its high morbidity and lack of effectiveness. Techniques of disrupting the blood–brain barrier have been used before chemotherapy infusion to improve the delivery of chemotherapeutic agents to tumour cells within the environment of a normal blood–brain barrier. This has resulted in substantially increased neurotoxicity to the normal brain without significantly improving survival. Intracarotid chemotherapy suffers from serious limitations— the perfusion of the tumour mass is less than expected because most tumours are not supplied entirely by one carotid artery and ‘streaming’ of the cytotoxic agent results in very high doses of chemotherapy to small areas, with relative hypoperfusion in other regions. Complications such as serious retinal damage and neurotoxicity have further reduced the attractiveness of this technique.

Radiotherapy

Attempts to enhance the effect of radiotherapy have included the use of radiosensitizers, such as metronidazole and misonidazole, which increase the radiosensitivity of hypoxic tumour cells without a corresponding increase in the sensitivity of euoxic cells. However, the clinical trials have shown only a marginal advantage. The use of interstitial brachytherapy, involving stereotactically implanted radioactive sources into the tumour, has the advantage of applying a high dose of radiotherapy to the tumour while sparing the surrounding brain. However, the clinical trials performed so far have resulted in a high incidence of radionecrosis to the surrounding brain and improvements in the technique will need to be devised before this method would become acceptable. Similarly, stereotactic radiosurgery, that involves radiation to a very highly focused area, is of limited use as it does not target the infiltrative tumour cells that are responsible for tumour recurrence.

Hyperthermia

This has inherent basic limitations as, although cell death occurs at approximately 42°C, damage to the surrounding brain occurs at 45°C, so there is a very narrow therapeutic index. In addition, there is a marked tolerance of tumour cells to hyperthermia and the treatment has not been effective.

Immunotherapy

The possibilities for immunotherapy as an adjuvant treatment have been investigated for many years. Investigations have included the use of active immunotherapy techniques and, more recently, the application of adoptive immunotherapy. This technique involves stimulating peripheral blood lymphocytes in vitro with human recombinant interleukin-2 to produce lymphokine activated killer cells (LAK cells) which can be administered in conjunction with interleukin-2. However, the LAK cells do not cross the blood–brain barrier and so need to be injected in close proximity to the tumour cells. Recent studies using this technique have been disappointing.

Photodynamic therapy

This is a technique that offers special advantages as an adjuvant therapy of malignant brain tumours since it has been shown to be an effective method of controlling local tumours. The technique involves the selective uptake of sensitizer into the brain tumour, followed by open or intraoperative irradiation of the sensitized tumour cells with light of an appropriate wavelength to activate the sensitizer and selectively destroy the tumour cells. Clinical studies using this method have shown a favourable trend, although formal phase III studies have not been undertaken.

Gene therapy

Experimental therapies of glioma at present being investigated involve the use of retrovirus, adenoviruses or adeno-associated viruses to carry a variety of gene therapies to the cancer cell. It is hoped that as these treatments are refined over the next decade they will be useful in the treatment of cerebral glioma.

 

 

Oligodendroglioma

Oligodendrogliomas are responsible for approximately 5% of all gliomas and occur throughout the adult age group with a maximal incidence in the 5th decade. The tumour is rare in children.

Pathology

Nearly all oligodendrogliomas occur above the tentorium; most are located in the cerebral hemispheres and about half of these are in the frontal lobes. Oligodendrogliomas may project into either the 3rd or lateral ventricles. Oligodendrogliomas have the same spectrum of histological appearance as astrocytomas, ranging from very slow growing, benign tumours to a more rapidly growing, malignant variety with abundant mitotic figures, endothelial proliferation and foci of necrosis. Calcium deposits are found by histological examination in up to 90% of oligodendrogliomas. Unlike the astrocyte group, most oligodendrogliomas are well differentiated. Not infrequently tumours have mixed histology, with both oligodendroglial and astroglial features.

Clinical presentation

The presenting features are essentially the same as for the astrocyte group but, as these tumours are more likely to be slow growing, epilepsy is common, occurring in 80% of patients and seen as an initial symptom in 50%. The features of raised intracranial pressure and focal neurological deficits are each present in approximately one-third of patients.

As for astrocyte tumours, MRI with contrast may be beneficial but other investigations are usually unnecessary.

Radiological investigation

CT scanning and MRI are the fundamental investigations. They will confirm the diagnosis of an intracranial tumour and in many cases the diagnosis of oligodendroglioma will be highly probable. Calcification will be present in 90% of cases and over half show contrast enhancement (Fig. 6.11).

http://trialx.com/curetalk/wp-content/blogs.dir/7/files/2011/05/diseases/Oligodendroglioma-3.jpg
 

 

 

 

 

 

 

 

 


Fig. 6.11 Oligodendroglioma

Treatment and results

Treatment involves:

• surgical resection

• radiotherapy

• other adjuvant treatments.

The standard treatment for oligodendroglioma has been an aggressive resection of the tumour followed by radiation therapy, although radiotherapy would now not be given to low-grade tumours, and utilized only for the intermediate- or high-grade oligodendroglial tumours. Oligodendrogliomas have been shown to be more sensitive to chemotherapy than the astrocytoma tumours, especially if the oligodendrogliomas belong to the group with loss of heterozygosity OF chromosome 1p or 19q.

The survival of patients depends on the degree of histological malignancy. Five-year survival rates are between 30 and 50% with a small number of patients living for many years (up to 5% for 20 years). However, many tumours with histological features of oligodendroglioma also have a component of astrocyte-derived cells, usually anaplastic astrocytoma, and the tumour behaves biologically and clinically as an anaplastic astrocytoma rather than an oligodendroglioma.

 

 

 

Recurrent cerebral glioma

As discussed earlier, most high-grade cerebral gliomas will recur within 1 year of the initial treatment with surgery and radiotherapy. Lowgrade tumours may either recur as a continuing progression of the slow growth or, alternatively, the histological characteristics may alter and the tumour may become more anaplastic and rapidly growing.

The clinical presentation of a recurrent tumour will be evidenced by either a progression of the focal neurological signs or the signs of an increase in the intracranial pressure. The diagnosis will be confirmed by CT scan or MRI in most cases. The major differential diagnosis is postradiotherapy radiation necrosis, which may develop as early as 4 months or as late as 9 years after radiotherapy.

The radiological features of necrosis are an avascular mass, and the diagnosis may be suspected from the dose of radiotherapy that has been administered. However, there may be considerable difficulty in differentiating necrosis from recurrent glioma, and sometimes an operation is required both for definitive diagnosis and to remove the mass.

The initial deterioration following a diagnosis of recurrent glioma can usually be temporarily halted by the use of steroid medication. The major decision is whether further surgery and other adjuvant therapy should be undertaken. In general, a further operation involving debulking of the tumour would be considered if:

• the patient is less than 65 years old

• there has been a symptom-free interval of 1 year or more since the first operation

• debilitating irreversible neurological signs are absent

• the tumour is in an accessible position and repeat surgery would not result in additional morbidity.

Adjuvant therapies

Adjuvant therapies have limited benefit for patients with recurrent tumour and, considering the morbidity involved, may not be indicated. Chemotherapy, utilizing temozolomide administered orally, has shown to have a temporary benefit in up to 40% of patients. Other chemotherapy agents, especially the nitrosourea compounds, have much greater toxicity.

 

 

Ependymoma

Ependymomas are glial neoplasms arising from the ependyma and constitute approximately 5% of all gliomas. Approximately two-thirds of ependymomas occur in the infratentorial compartment and most of these present in children, adolescents and young adults. The supratentorial ependymomas occur mostly in adults.

Pathology

The tumour arises from the ependyma of the ventricle and, although predominantly intraventricular, the tumour often invades into the adjacent cerebellum, brainstem or cerebral hemisphere. Fourth ventricular tumours usually arise from the floor or lateral recess of the 4th ventricle and they may extend into the subarachnoid space to encase the medulla or upper cervical spinal cord. Alternatively, the tumour may grow laterally through the foramen of Luschka and into the cerebellopontine angle. The tumours are well demarcated, nodular, soft and pale. Calcification is common, especially in supratentorial ependymomas. There are numerous histological classification systems of ependymomas, and the World Health Organization classification divides these tumours into cellular, papillary and clear cell types of non-anaplastic ependymoma and anaplastic ependymoma.

The myxopapillary variety is a slow-growing distinct variant of ependymoma that occurs in the cauda equina. In an adult the subependymoma variant may be encountered as an incidental autopsy finding—a discrete nodular mass based in the brain’s ventricular surface, particularly the floor or lateral recess of the 4th ventricle or the septum pellucidum—or it may be large enough to present clinically. It is usually heavily calcified and is composed of cells with astrocytic as well as ependymal features.

The papillary and anaplastic varieties of ependymoma are responsible for the majority of clinically symptomatic ependymomas. The cellularity and architecture of the ependymomas vary but a diagnostic feature is the presence of rosettes, and most ependymomas contain areas in which perivascular pseudorosettes are conspicuously developed. In these formations the blood vessel is surrounded by an eosinophilic halo composed of the radiating tapering processes of the cells. Blepharoplasts frequently occur in ependymomas but may be difficult to visualize. These are tiny intracytoplasmic spherical or rod-shaped structures which represent the basal bodies of cilia, and are most frequently encountered in the apical portion of cells that form ependymal rosettes.

Clinical presentation

Posterior fossa ependymomas

Details will be discussed in the section on paediatric tumours (p. 91). Patients present with features of raised intracranial pressure due to hydrocephalus as a result of obstruction of the 4th ventricle, ataxia due to cerebellar involvement, and occasionally features of brainstem pressure or infiltration.

Supratentorial tumours

Virtually all patients with supratentorial ependymomas present with features of raised intracranial pressure, often due to hydrocephalus as a result of obstruction of the CSF pathways. Ataxia is common and focal neurological deficits may occur due to involvement of the underlying cerebral hemisphere.

Radiological investigation

The CT scan and MRI will show a tumour that arises in the ventricle and enhances after administration of intravenous contrast. Calcification is common in tumours arising from the lateral ventricles (Fig. 6.12). There is frequently associated hydrocephalus. In the posterior fossa differentiation from a medulloblastoma may be difficult. 

Treatment

The treatment of ependymomas is initially surgical, with an attempt to perform a radical macroscopic resection of the tumour. Supratentorial tumours are often very large and may extend throughout the lateral and 3rd ventricles, but the associated hydrocephalus makes the excision of the intraventricular portion feasible. However, the tumour may arise from the ventricular wall in

the region of the basal ganglia and blend imperceptibly with the underlying cerebral structures so that a complete excision is not possible. Fourth ventricular tumours can be excised from the ventricle but microscopic infiltration into the underlying brainstem cannot be removed surgically.

Postoperative radiation therapy is advisable and, as these tumours may spread through the CSF pathways, sometimes whole neuraxis radiation is recommended.

The prognosis is related to the degree of anaplasia of the tumour and for intratentorial tumours varies from 20% to 50% 5-year survival. The prognosis for the supratentorial tumours is better, particularly in adults.

 

Pineal tumours

Tumours arising in the region of the pineal gland are mostly not of pineal origin, but are generally called ‘pineal’, as they have a similar clinical presentation.

The tumours are relatively uncommon, accounting for 0.5% of all intracranial tumours.

However, they occur more frequently in Japan and China, where the incidence is up to 5%. Most tumours make their clinical appearance between 10 and 30 years of age.

Classification

Pineal region tumours are classified in decreasing frequency as:

 • germinoma

• teratoma

• pineocytoma

• pineoblastoma

• miscellaneous

• glioma

• cyst.

Germinoma is the most common pineal region tumour and is similar in histological appearance to germinoma of the gonads and mediastinum; it occurs predominantly in males. These tumours may also arise in the suprasellar region, and synchronous tumours in both the pineal and suprasellar region occur occasionally. Teratoma is like germinoma; it also arises from displaced embryonic tissue. The other tumour types occur less commonly.

Clinical presentation

Patients with pineal tumours present with:

• raised intracranial pressure

• neurological signs due to focal compression

• endocrine disturbance.

Raised intracranial pressure. The features of raised intracranial pressure, such as headaches, drowsiness and papilloedema, are due to hydrocephalus, which is a result of the tumour occluding the aqueduct of Sylvius.

Focal compression. Compression of the efferent cerebellar pathways in the superior cerebellar peduncle results in limb ataxia and distortion of the quadrigeminal plate, produces limitation of upgaze, convergence paresis with impairment of reaction of pupils to light and accommodation (Parinaud’s syndrome), and may result in convergence-retraction nystagmus on upgaze (Koerber–Salius–Elschnig syndrome).

Endocrine disturbance. Endocrine disturbances are uncommon but include precocious puberty in 10% of patients, almost invariably male, and diabetes insipidus in 10%. The endocrine effects can either be due to direct tumour involvement of the hypothalamus or result from the secondary effects of hydrocephalus.

Radiological investigations

CT scan and MRI will show a pineal region tumour and will often suggest the correct pathological diagnosis (Fig. 13). On CT scan, before contrast, a germinoma will be a hyperdense lesion in the region of the pineal gland infiltrating into the surrounding tissue and there will be uniform vivid enhancement following intravenous contrast. Calcification is uncommon. On MRI germinomas are relatively isointense to normal white matter on T1-weighted images and slightlyhyperintense on T2-weighted scans. Gadolinium contrast defines the tumour well as germinomas enhance markedly and homogeneously. 

Management

This consists of surgery and radiotherapy. A ventriculoperitoneal shunt or drainage of CSF by a 3rd ventriculostomy may be required if the hydrocephalus is severe.

There is controversy over whether the definitive treatment should be an attempt at surgical excision or radiotherapy. As most of the tumours are germinomas, and these tumours are very radiosensitive, a course of radiotherapy can be given as the initial treatment if the radiological appearance is typical for germinoma. If serial CT scans show the tumour has failed to respond to radiotherapy then surgery may be necessary. Alternatively, if the features on the initial CT and MRI scans are atypical, and the lesion does not resemble a germinoma, exploration of the tumour and surgical excision may be appropriate as the initial procedure.

The preferred surgical approach is usually by a posterior fossa craniotomy, above the cerebellum and below the tentorium cerebelli. Alternative supratentorial surgical exposures include approaching the tumour through the corpus callosum or by retracting the occipital lobe.

 

 

Metastatic tumours

Metastatic tumours are responsible for approximately 15% of brain tumours in clinical series but up to 30% of brain tumours reported by pathologists. Approximately 30% of deaths are due to cancer and 1 in 5 of these have intracranial metastatic deposits at autopsy. The metastatic tumours most commonly originate from:

• carcinoma of the lung

• carcinoma of the breast

• metastatic melanoma

• carcinoma of the kidney

• gastrointestinal carcinoma.

In 15% a primary origin is never found. Most metastatic tumours are multiple and onethird are solitary. In about half of these systemic spread is not apparent. The incidence of tumours in the cerebrum relative to the cerebellum is 8 : 1, and most occur in the distribution of the middle cerebral artery. The size of the tumours may vary considerably if the deposits are multiple. Metastatic tumours are often surrounded by intense cerebral oedema.

Clinical presentation

The interval between diagnosis of the primary cancer and cerebral metastases varies considerably. In general, secondary tumours from carcinoma of the lung present relatively soon after the initial diagnosis, with a median interval of 5 months. Although cerebral metastases may present within a few months of the initial diagnosis of malignant melanoma or carcinoma of the breast, some patients may live many years (up to 15 years) before an intracranial tumour appears. The presenting features are similar to those described for other intracranial tumours:

• raised intracranial pressure

• focal neurological signs

• epileptic seizures.

Headache and vomiting, indicative of raised intracranial pressure, occur in most patients and the presenting history is usually short, often only a few weeks or months. The increased intracranial pressure will be caused by either the tumour mass and surrounding oedema or, in posterior fossa tumours, obstructive hydrocephalus. The pattern of focal neurological signs will depend on the position of the tumour deposits and the patient may present with a progressive hemiparesis or speech disturbance with supratentorial tumours or gait ataxia with cerebellar tumours. Epileptic seizures occur in approximately 25% of patients and may be either focal or generalized.

Occasionally, metastases, especially melanoma or choriocarcinoma, present following an intracerebral haemorrhage.

Radiological investigations

CT scan or MRI will diagnose the metastatic tumour and will show whether the deposits are solitary or multiple. Most metastatic tumours are relatively isodense on the unenhanced CT scan and they enhance vividly after intravenous contrast injection. Tumours that may be hyperdense prior to contrast are melanoma, choriocarcinoma, mucoid adenocarcinoma (e.g. from the gastrointestinal tract) and 50% of lymphomas. There is usually considerable surrounding cerebral oedema with distortion of the ventricular system. MRI following gadolinium contrast will demonstrate small metastatic tumours often not visible on the CT scan (Fig. 15). 

Treatment

Steroid medication (e.g. dexamethasone) will control cerebral oedema and should be commenced immediately if there is raised intracranial pressure.

Surgery to remove the metastasis is indicated if:

• there is a solitary metastasis in a surgically accessible position

• there is no systemic spread.

Removal of a solitary secondary is preferable only if the primary site of origin has been, or will be, controlled. However, excision of a single metastasis will provide excellent symptomatic relief and consequently may be indicated even if the primary site cannot be treated satisfactorily. Surgery is, of course, mandatory if the diagnosis is uncertain.

Radiotherapy, together with steroid medication to control cerebral oedema, is used to treat patients with multiple cerebral metastases and may be advisable following the excision of a single metastasis. The treatment, up to 45 gray, is usually given in a 2-week course.

Over the past decade stereotactic radiosurgery utilizing a highly focused beam of radiation has been used to treat single and multiple cerebral metastases. The therapy does seem to be effective in some cases and its role relative to surgery is being evaluated.

Anticonvulsant medication is given both to patients who have suffered epileptic seizures and as a prophylactic measure.

Prognosis

About 30% of patients with solitary metastatic deposits from carcinoma of the lung or melanoma and 50% of patients with carcinoma of the breast survive 1 year following surgical excision. In those patients where the source of the metastatic tumours is undetermined, about 50% survive 1 year.

 

Leptomeningeal metastases

Meningeal carcinomatosis is widespread, multifocal seeding of the leptomeninges by systemic cancer. The clinical presentation includes:

• hydrocephalus, causing headaches and vomiting

• cranial nerve abnormalities due to direct invasion by the tumours

• spinal root involvement due to local infiltration.

The CT scan or MRI findings may be subtle but frequently show excessive enhancement of the meninges. Lumbar puncture can be performed if there is no evidence of raised intracranial pressure. Malignant cells may be seen in the CSF, the protein concentration is increased and the glucose reduced.

Paediatric tumours

Intracranial tumours are the most common form of solid tumours in childhood, with 40% of the tumours occurring above the tentorium cerebelli. The most common supratentorial tumours are astrocytomas, followed by anaplastic astrocytomas and glioblastoma multiforme. Craniopharyngioma occurs more commonly in children than in adults and is situated in the suprasellar region. Other, less common, supratentorial tumours include primitive neuroectodermal tumours (PNETs), ependymomas, ganglioglioma and pineal region tumours.

Posterior fossa tumours

Sixty per cent of paediatric brain tumours occur in the posterior fossa. The relative incidence of the tumours is:

1 cerebellar astrocytoma 30%

2 medulloblastoma (infratentorial primitive neuroectodermal tumour) 30%

3 ependymoma 20%

4 brainstem glioma 10%

5 miscellaneous 10%:

(a) choroid plexus papilloma

(b) haemangioblastoma

(c) epidermoid, dermoid

(d) chordoma.

Clinical presentation

The presenting clinical features of posterior fossa neoplasms in children are related to:

• raised intracranial pressure

• focal neurological signs.

Raised intracranial pressure

This is the most common presenting feature. It is due to hydrocephalus caused by obstruction of  the 4th ventricle and is manifest by headaches, vomiting, diplopia and papilloedema. The headaches begin insidiously, gradually becoming more severe and frequent; they are worst in the early morning. There is usually no specific headache localization. Vomiting is frequently associated with the headaches and may temporarily relieve the headache. Raised intracranial pressure may result in a strabismus causing diplopia due to stretching of one or both of the 6th (abducens) cranial nerves. This is a so-called ‘false localizing sign’. Papilloedema is usually present at the time of diagnosis. In infants, an expanding head size is an additional sign of raised intracranial pressure.

Focal neurological signs

These are due to the tumour invading or compressing the cerebellum (nuclei and tracts), the brainstem and cranial nerves. Truncal and gait ataxia result particularly from midline cerebellar involvement. Horizontal gaze paretic nystagmus often occurs with tumours around the 4th ventricle. Upbeat vertical nystagmus is indicative of brainstem involvement.

Disturbances of bulbar function, such as difficulty in swallowing with nasal regurgitation of fluid, dysarthria and impaired palatal and pharyngeal reflexes, result from brainstem involvement. In addition, compression or tumour invasion of the pyramidal tracts may result in hemiparesis and, if the ascending sensory pathways are involved, sensory disturbance will occur in the trunk and limbs.

The tumour may directly envelop the lower cranial nerves—glossopharyngeal, vagal, spinal accessory and hypoglossal—as well as the 7th cranial nerve.

Neck stiffness and head tilt may occur in children with posterior fossa neoplasms, and may be due to herniation of a cerebellar tonsil or tumour tissue resulting in dural irritation.

Investigations

CT scan and MRI have replaced the need for the previous radiological investigations that included radio-isotope brain scanning, air ventriculography and posterior fossa angiography. The CT scan and/or MRI will show the presence of a posterior fossa tumour, its position and whether it arises primarily in the brainstem, 4th ventricle or the cerebellum (Figs 20–24).

Management

The treatment of posterior fossa tumours involves:

• surgery

• radiotherapy

• chemotherapy.

Apreliminary CSF shunt may need to be performed in a child with severely raised intracranial pressure due to hydrocephalus. The CSF diversion can be achieved by either an external drain or a ventriculoperitoneal shunt. An external drain is a temporary measure only, because of the risk of infection. A ventriculoperitoneal shunt provides immediate and controlled relief of intracranial hypertension and the subsequent posterior fossa operation can be performed as a planned elective procedure, rather than an urgent operation in suboptimal conditions. A criticism of a preoperative ventriculoperitoneal shunt is that it might promote the metastatic

spread of tumour. A filtering chamber in the shunt system may lessen this risk but this predisposes to shunt malfunction.

Steroid medication to control local oedema is commenced preoperatively. The operation is performed in either the sitting or prone position through a vertical midline incision. A posterior fossa craniotomy is performed, usually with excision of the bone down to and around the foramen magnum.

Postoperative care involves careful monitoring of the neurological signs. Postoperative haemorrhage or oedema may result in rapid deterioration of the neurological state, and in respiratory arrest. An urgent CT scan may indicate the cause and site of the problem but the deterioration may be so rapid that the wound may need to be reopened without the benefit of prior scanning. If a ventriculoperitoneal shunt has not been inserted prior to tumour removal an exacerbation of the obstructive hydrocephalus may occur if the tumour excision has failed to relieve the CSF obstruction. Disturbances of bulbar and lower cranial nerve function may cause difficulty in swallowing. Nasogastric feeding may be necessary until the protective mechanisms return, and great care should be taken to avoid aspiration.

 

Medulloblastoma

Medulloblastoma, also referred to as an infratentorial PNET, is a malignant tumour usually arising in the midline from the cerebellar vermis, although it may occur more laterally in a cerebellar hemisphere in older patients. The tumour expands to invade the adjacent cerebellum and large tumours completely fill the 4th ventricle. Fig.20

  Presenting features. The presenting features are related to hydrocephalus and cerebellar dysfunction. Truncal ataxia is typically present in children with medulloblastoma but cranial nerve deficits, except for a 6th nerve palsy, are uncommon in the early stages.

Surgery. At surgery the cerebellar vermis is split in the midline and it is usually possible to obtain a gross macroscopic excision of the tumour with complete removal from the 4th ventricle.

Radiation therapy. Medulloblastoma is relatively radiosensitive and radiation therapy is recommended to the entire neuraxis because of the tendency of the tumours to seed along the CSF pathways.

Chemotherapy. Adjuvant chemotherapy is usually recommended Young children are exquisitely sensitive to the neurotoxicity due to radiation therapy, such that the possibility of utilizing chemotherapy alone and postponing the use of radiotherapy has been trialled.

Prognosis. Although the combination of radical surgery and irradiation has improved the prognosis, the 5-year survival rate is approximately 40%.

 

Cerebellar astrocytoma

The cerebellar astrocytoma is frequently a benign, slowly growing cystic tumour which is the most favourable of all the intracranial paediatric neoplasms. The tumours may arise in either the hemisphere or vermis and frequently consist of a large tumour cyst with a relatively small solid component in the wall of the cyst (see Fig. 21). Less frequently the tumour may be entirely solid with little or no cystic component. Histologically, the solid portion of the tumour is usually a Grade 1 or 2 astrocytoma.  

Presenting features. The clinical presenting features are similar to those of a medulloblastoma, but as the tumour may be located more laterally the presenting features are accompanied by ipsilateral cerebellar disturbance. The duration of symptoms is variable but tends to be longer than with medulloblastoma, averaging 6–12 months.

Surgery. Acomplete surgical excision is usually possible and it is only necessary to excise the solid component from the cystic tumour.

Radiation therapy. Postoperative radiation therapy is not usually indicated if an excision has been possible. The prognosis is the most favourable of all intracranial childhood tumours with a cure rate in excess of 75%.

 

Ependymoma

The ependymoma of the 4th ventricle arises from the floor of the 4th ventricle and is attached to, and may infiltrate, the underlying brainstem

Pathological features and histology are described earlier.

Presenting features. The presenting features are similar to those described for a medulloblastoma,although the initial symptoms and signs are usually due to hydrocephalus. Involvement of the dorsal brainstem results in unilateral or bilateral facial weakness.

Surgery. The surgical excision of the ependymoma involves splitting the inferior vermis to obtain access to the 4th ventricle. It is usually possible to perform a gross macroscopic excision of the tumour from the ventricle and adjacent cerebellum but, as the tumour often originates from the floor of the 4th ventricle, total excision is rarely possible.

Radiation therapy. Postoperative radiation therapy is usually administered to the posterior fossa and, as the tumour seeds along the CSF pathways, entire neural axis irradiation is often recommended, particularly in the higher-grade ependymoma.

There is no definite advantage from adjuvant chemotherapy, although it may be used at the time of tumour recurrence.

 

Brainstem glioma

The brainstem glioma arises predominantly in the pons, less frequently in the medulla but may infiltrate extensively throughout the brainstem.

Clinical presentation. The clinical presentation characteristically includes progressive multiple bilateral cranial nerve palsies with involvement of pyramidal tracts and ataxia. Facial weakness and 6th cranial nerve palsy are common and an internuclear ophthalmoplegia is indicative of an intrinsic brainstem lesion. The child’s personality often changes—they become apathetic. Raised

intracranial pressure is less common than with other paediatric posterior fossa neoplasms, as obstruction of the 4th ventricle or aqueduct of Sylvius occurs late in the illness.

The CT and MRI appearance is of an expanded brainstem. MRI has considerably improved the accuracy of the diagnosis (Fig. 6.23). 

Surgery. Surgical treatment is not usually indicated, although either an open or a stereotactic biopsy may be performed to confirm the diagnosis.

Radiation therapy. Palliative radiation therapy is the only treatment. The tumour usually causes death within 24 months of diagnosis, although some patients with low-grade tumours will live longer.

Chemotherapy has limited benefit.

 

BENIGN BRAIN TUMOURS

 

The benign brain tumours may be intimately associated with, and surrounded by, the adjacent brain, but the tumour cells do not invade the underlying brain. This is in contradistinction to the gliomas, which are intrinsic brain tumours actively invading the adjacent brain.

 

Meningioma

Meningiomas are the most common of the benign brain tumours and constitute about 15% of all intracranial tumours, being about one-third of the number of gliomas. Although they may occur at any age, they reach their peak incidence in middle age, are very uncommon in children and occur more frequently in women than men. The term meningioma was introduced by Harvey Cushing in 1922, although the tumour had been described in the late eighteenth century. The tumour arises from the arachnoid layer of the meninges, principally the arachnoid villi and granulations.

Aetiology

As for other brain tumours, no definite aetiological factor has been identified. However, the possibility that head trauma predisposes to the development of meningioma has been the subject of controversy for many years. Although epidemiological studies do not support trauma as an aetiological factor, there have been cases reporting the development of meningiomas at the site of substantial meningeal trauma. Meningiomas are known to occur following low levels of irradiation as was given in the past for tinea capitis, and an analysis of the Nagasaki atomic bomb survivors found a high correlation between the incidence of meningiomas and the distance from the epicentre of the explosion. Meningiomas occur with a high frequency in patients with neurofibromatosis type 2 (NF2) (often multiple). This association has prompted cytogenetic studies, which have shown that monosomy of chromosome 22 is the most common chromosomal abnormality noted in meningiomas, occurring in 50–80% of sporadic tumours. In addition, alterations of many other chromosomes (including chromosomes 1, 6, 9, 10, 11, 13, 14, 18 and 19) have been noted to be involved in the formation and progression of meningioma.

The importance of sex hormones and their receptors in meningioma is suggested by the 2–4 times incidence in females. Oestrogen binds in less than 30% of meningiomas, with the majority of those receptors being type II subtype, that have a lower affinity and specificity for oestrogen than the classic type I receptor usually found in breast cancer. Progesterone receptors are much more commonly associated with meningiomas, occurring in 50–100% of tumours tested.

Position of meningiomas

Meningiomas arise from the arachnoid layer of the meninges, especially the arachnoid cap cells. The most common location is in the parasagittal region arising either from the wall of the superior sagittal sinus (parasagittal) or from the falx  (falcine). Less frequently the tumours may arise from the convexity of the cranial vault, where they are particularly concentrated in the region of the coronal suture. Sphenoidal ridge meningiomasare divided into those that arise from the inner part of the lesser wing of the sphenoid and the adjacent anterior clinoid process, and those arising from the outer sphenoidal ridge, comprising the greater wing of the sphenoid and theadjacent pterion (the junction of the temporal, parietal and frontal bones). Less frequently, the tumours may arise from the olfactory groove, tuberculum sella (suprasellar), floor of the middle cranial fossa, cavernous sinus or posterior fossa (Table 7.1). Meningiomas usually occur as a single intracranial tumour but multiple intracranial meningiomas may present in NF2.

 

Pathology

Unlike gliomas, where the classification system is based on the histological appearance of the tumour, meningiomas are usually classified according to their position of origin rather than their histology. The reason for this is that the biological activity of the tumour, the presenting features, the treatment and prognosis are all related more to the site of the tumour than to the histology.

The major histological types are listed below.

• Syncytial or meningotheliomatous—sheets of cells with varying amounts of stroma.

• The transitional type is characterized by whorls of cells which may undergo hyalin degeneration with subsequent deposition of calcium salts. These calcified concentric psammoma bodies form the characteristic feature of many transitional meningiomas but they may also be present in the syncytial or fibroblastic types.

• The fibroblastic type contains abundant reticulin and collagen fibres.

• Angiomatous meningiomas are much less common and their characteristic feature is the predominance of vascular channels separated by sheets of cells. Histologically, these tumours resemble cerebellar haemangioblastomas.

• Malignant meningiomas occur infrequently. The indications of malignancy include cellular pleomorphism, necrosis, increased numbers of mitotic figures and local invasion of brain. Atypical meningiomas are tumours that lack the histological features of malignancy, but have a biological behaviour intermediate between the typical and malignant meningioma. These tumours are most likely to recur.

Clinical presentation

Meningiomas present with features of:

• raised intracranial pressure

• focal neurological signs

• epilepsy.

The position of the tumour will determine the features of the clinical presentation. The tumours grow slowly and there is frequently a long history, often of many years, of symptoms prior to the diagnosis.

Parasagittal tumours

These tumours most often arise in the middle third of the vault and the patient may present with focal epilepsy and paresis, usually affecting the opposite leg and foot as the motor cortex on the medial aspect of the posterior frontal lobe is affected. Tumours arising anteriorly are often bilateral and patients present with features of raised intracranial pressure. As these tumours involve the frontal lobes, pseudopsychiatric symptoms, as well as impairment of memory, intelligence and personality, may occur. Urinary incontinence is occasionally a symptom of a large frontal tumour, especially if it is bilateral. Tumours arising from the posterior falx may affect the parieto-occipital region and produce a homonymous hemianopia. If the tumour lies above the calcarine fissure the inferior quadrant is more affected; when the tumour is below the fissure the upper quadrant is predominantly affected.

http://www.nature.com/modpathol/journal/v15/n6/images/3880585f2.jpg

Fig. 7.2 Parasagittal meningioma.

 

Convexity tumours

Convexity tumours may grow to a large size if situated in front of the coronal suture. They present with raised intracranial pressure. More posterior tumours will cause focal neurological symptoms and focal epilepsy. 

Sphenoidal ridge tumours

Tumours arising from the inner sphenoidal ridge cause compression of the adjacent optic nerve and patients may present with a history of uniocular visual failure. If the tumour is large enough to cause raised intracranial pressure papilloedema will develop in the contralateral eye. syndrome is known as the Foster Kennedy. Inner sphenoidal ridge tumours may also cause compression of the

olfactory tract, resulting in anosmia. Patients with tumours involving the outer sphenoidal ridge present with features of raised intracranial pressure, often severe papilloedema with relatively inconspicuous localizing symptoms or signs. Tumours in this region occur as a thin sheet, and are known as ‘en plaque’. They may cause an excessive bony reaction (hyperostosis) resulting in proptosis.

 

Fig. 7.4 (a) CT scan. Hyperostosis of the left sphenoidal ring causing unilateral proptosis due to a sphenoidal ring meningioma. (b) MRI. Inner sphenoidal wing meningioma.

 

Olfactory groove tumours (Fig. 7.5)

Olfactory groove meningiomas cause anosmia, initially unilateral and later bilateral. The presenting features may include symptoms of raised intracranial pressure, and failing vision either from chronic papilloedema or from direct compression of the optic nerve or chiasm causing visual field defects. These tumours may also present with the Foster Kennedy syndrome and the intellectual and psychiatric problems caused by frontal lobe compression described for inner spheroidal ridge meningiomas. 

Suprasellar tumours

Suprasellar meningiomas arising from the tuberculum sellae will cause visual failure and a bitemporal hemianopia, but the lack of endocrine disturbance will distinguish the clinical presentation of this tumour from that of a pituitary tumour.

Ventricular tumours

Tumours arising in the lateral ventricle present with symptoms of raised intracranial pressure extending over several years and associated with a mild global disturbance of function of one hemisphere and frequently a homonymous hemianopia.

 

 

Posterior fossa tumours

Posterior fossa tumours may arise from the cerebellar convexity or from the cerebellopontine angle or clivus. The cerebellopontine angle tumours simulate an acoustic neuroma with symptoms involving the acoustic nerve, trigeminal nerve and facial nerve, ataxia due to cerebellar involvement and raised intracranial pressure, often due to hydrocephalus caused by obstruction of the 4th ventricle. Meningiomas arising from the clivus or the foramen magnum region may compress the brainstem directly. 

Radiological investigations

The CT scan appearance shows a tumour of slightly increased density prior to contrast; it enhances vividly and uniformly following intravenous contrast. Hyperostosis of the cranial vault may be a focal process at the site of the tumour attachment or, as seen with en plaque meningioma, a more diffuse sclerosis. These bone changes may also be seen on plain skull X-ray.

Magnetic resonance imaging will demonstrate meningiomas following the intravenous injection of gadolinium contrast  Meningiomas are usually isointense on T1- weighted images, but enhance intensely and usually homogeneously following administration of gadolinium.

Cerebral angiography is no longer necessary as a diagnostic investigation but may be useful preoperatively to ascertain the position of the cerebral vessels. It will demonstrate external carotid artery supply to the tumour with a characteristic tumour blush, differentiating it from a glioma or metastatic tumour (Fig. 7.12). Angiography also allows preoperative embolization of the tumour, if necessary.

Preoperative management

Meningiomas are frequently surrounded by severe cerebral oedema and patients should be treated with high-dose steroids (dexamethasone) prior to surgery if possible. Preoperative embolization of the tumour vasculature may be considered advisable in some anterior basal and sphenoidal wing tumours where the major Vascular supply is not readily accessible in the early stages of the operation.

Treatment

The treatment of meningiomas is total surgical excision, including obliteration of the dural attachment. Although this objective is usually possible there are some situations where complete excision is not possible because of the position of the tumour. Tumours arising from the clivus, in front of the brainstem or those situated within the cavernous sinus, are notoriously difficult to excise without causing serious morbidity. Radiation therapy may be used to treat residual tumours following subtotal resection, in order to reduce the risk of recurrent growth. Stereotactic radiotherapy has been used to treat small meningiomas (less than 3 cm in diameter), particularly if the tumours are located in portions not easily amenable to surgery, or in the elderly or medically infirm patient. Clinical studies have shown short-term control rates of over 90%, but long-term studies will be necessary to prove the efficacy and safety of focused radiation treatment.

Postoperative management

The postoperative care of patients following excision of a meningioma involves the routine management of patients following a craniotomy but with particular attention to the minimization of cerebral oedema. Steroid therapy is continued initially and gradually tapered. Care is taken to avoid excessive hydration and the patient is nursed with the head of the bed elevated to promote venous return. Neurological deterioration requires urgent assessment and a CT scan will determine the pathological cause, either postoperative haemorrhage or cerebral oedema.

Tumour recurrence

The risk of tumour recurrence depends on the extent of tumour excision. When the tumour and its dural origins are completely excised, the risk of recurrence is remote. The most common source of recurrence is from a tumour that has invaded a venous sinus and which was not resected (e.g. superior sagittal sinus or cavernous sinus). Recurrence is more common if the tumour has histological features of malignancy.

 

Meningeal haemangiopericytoma

Meningeal haemangiopericytoma is a malignant neoplasm with sarcoma-like behaviour. It was originally classified by Cushing and Eisenhardt in 1938 as an angioblastic variant of meningioma.The tumour’s radiological and macroscopic appearance resembles a vascular meningioma, but it arises from the meningeal capillary pericyte and typically contains a subpopulation of cells that express  actor VIIIa. The tumour incidence is 2–4% of meningioma and it is slightly more common in males than in females.

The presenting features are dependent on the tumour location, with symptoms usually being present for less than 1 year.

 

Acoustic neuroma

Acoustic schwannomas arise from the 8th cranial nerve and account for 8% of intracranial tumours. Schwannomas occur less frequently on the 5th cranial nerve and rarely involve other cranial nerves. The acoustic schwannoma takes origin from the vestibular component of the 8th cranial nerve near the internal auditory meatus, at the transition zone where the Schwann cells replace the oligodendroglia. As such it should more correctly be called a vestibular schwannoma, although the term acoustic neuroma or schwannoma is more commonly used.

Macroscopically, the acoustic schwannoma is lobulated with a capsule that separates it from the surrounding neural structures. Small tumours usually arise from within the internal auditory canal and occupy the porus of the internal auditory canal and, as the tumour grows, the 8th nerve is destroyed and the adjacent cranial nerves become stretched around the tumour. The 7th nerve is typically displaced on the ventral and anterior surface of the tumour and the trigeminal nerve is carried upwards and forwards by the upper pole. The 6th nerve lies ventral and usually medial to the major mass and the lower cranial nerves are displaced around the inferior pole of the tumour. As the tumour grows medially it compresses and displaces the cerebellum and distorts the brainstem. Large tumours will result in obstruction of the 4th ventricle and hydrocephalus.

Bilateral acoustic neuromas are the hallmark of neurofibromatosis type 2 (NF2), inherited as an autosomal dominant condition Clinical presentation

The presenting features will depend on the size of the tumour at the time of diagnosis. The earlier symptoms are associated with 8th nerve involvement. Tinnitus and unilateral partial or complete sensorineural hearing loss are the earliest features. Episodes of vertigo may occur but these may be difficult to distinguish from Menière’s disease. Although the tumour causes compressionof the facial nerve, the growth of the tumour is so slow that facial paresis is not evident until the tumour is large. At that stage 5th nerve compression may be evident, with diminished facial sensation and a depressed corneal reflex. Cerebellar involvement will result in ataxia, and compression of the pyramidal tracts from a very large tumour causing brainstem compression will cause a contralateral hemiparesis. If a large tumour has caused obstructive hydrocephalus the patient will also present with features of raised intracranial pressure.

Radiological investigations

The CT scan or MRI will show an enhancing tumour extending from the internal auditory canal into the cerebellopontine angle (Fig. 7.13). The internal auditory meatus will be widened indicating that the tumour has arisen from the 8th cranial nerve (Fig. 7.14). While there is no difficulty in diagnosing a tumour large enough to be evident on the CT scan, very small acoustic neuromas, which are predominantly within the internal auditory canal, may be more difficult to diagnose. These tumours may be seen on highquality CT scan but are particularly evident using MRI, especially following gadolinium contrast (Fig. 7.15), which is now the investigation of choice.

http://www.myhealthyfeeling.com/wp-content/uploads/2011/03/Acoustic-Neuroma-Surgery.jpg

Fig. 7.13 Acoustic neuroma.

 

Other investigations

Pure tone audiometry, by both air and bone conduction, is an essential part of the investigation of a patient with an acoustic neuroma, the most common finding being high-frequency hearing loss. Other special auditory tests include the use of brainstem auditory evoked responses which are particularly sensitive for changes in the retrocochlear auditory system; these are helpful in diagnosing a small intracanalicular tumour. Vestibular function is impaired early in patients with acoustic neuroma. The Hallpike caloric test is carried out with the patient supine on a couch and the head raised to 30°C above horizontal, bringing the horizontal canals into the vertical plane with the position of maximum sensitivity to thermal stimuli. Warm and cool water is irrigated and the nystagmus reaction observed. The caloric response on the side of the acoustic nerve tumour is depressed or absent.

Differential diagnosis

The major differential diagnoses for a cerebello-pontine angle tumour, in decreasing frequency, are:  meningioma, metastatic tumour, exophytic brainstem glioma, epidermoid tumour.

Treatment

The total excision of a large acoustic neuroma remains one of the major operative challenges in what Cushing has described as ‘the gloomy corner of neurologic surgery’.

The aim of the operation is complete resection of the tumour while sparing the adjacent neural structures. If the patient presents with a large tumour causing severe hydrocephalus and raised intracranial pressure, a preliminary ventriculoperitoneal shunt or ventricular drain may be considered. Steroid administration prior to surgery may be advisable if the tumour is large.

There are three basic approaches to the cerebellopontine angle: by excision of the labyrinth (translabyrinthine); through a posterior fossa craniectomy (suboccipital/retrosigmoid); or via the middle cranial fossa. The route chosen is governed by tumour size, the degree of hearing loss, the hearing level in the contralateral ear, and the surgical preference and expertise of the operator.

The major advantage of the translabyrinthine operation is that the facial nerve can be identified lateral to the tumour at an early stage in the dissection, and access to the fundus of the internal auditory meatus is excellent. Furthermore, retraction of the cerebellum is minimal and the risk of postoperative oedema is consequently less. The major disadvantage of this route is that residual hearing is irrevocably destroyed. translabyrinthine operation is favoured for large tumours, regardless of hearing level, and for medium-sized lesions with poor hearing. It provides a more direct approach to the cerebellopontine angle, and retraction of the cerebellum is negligible.

As a consequence of progressive improvements in operative results, particularly in mortality and facial nerve outcome, attention has

turned more recently to the ability to preserve useful hearing. The suboccipital operation provides good access to the cerebellopontine angle but, if hearing is to be conserved, tumour at the fundus of the internal auditory meatus may be difficult to expose under direct vision. For hearing preservation the retrosigmoid approach for tumours with up to 2 cm cerebellopontine angle extension is preferred.

Recently there has been renewed interest in the middle fossa approach for removal of intracanalicular tumours or those with a small cerebellopontine angle component, particularly where the tumour in the internal auditory canal extends to the fundus. Higher rates of hearing preservation have been reported without any compromise of facial nerve function, but this route provides more limited access to the cerebellopontine angle, and is therefore restricted to the treatment of small lesions. The middle fossa approach is preferred for intracanalicular tumours and for those with up to 1 cm cerebellopontine angle extension where tumour completely fills the internal auditory canal.

Stereotactic radiosurgery using either a 60CO Gamma Knife or a highly focused linear accelerator has been advocated for the treatment of smaller tumours, less than 3 cm in diameter. The control rates are greater than 90% over a 5-year period, but post-radiation neurological complications have been reported including delayed facial numbness and dysaesthesia, facial weakness and hearing loss. To minimize the complications of single-dose stereotactic radiosurgery many centres advocate fractionated stereotactic radiotherapy.

There is continuing debate as to the relative advantages of surgery and stereotactic radiation treatment. Whilst some clinicians advocate radiation treatment for smaller tumours, others would only recommend it for elderly or medically infirm patients or if there is residual tumour or regrowth after subtotal resection.

The management plan for patients with bilateral acoustic neuromas (NF2) is complex, and must be tailored for each patient, with the aim of preserving useful hearing for as long as possible, whilst minimizing the possible serious neurological complications from enlarging tumours causing cranial nerve, cerebellar and brainstem compression. Therapeutic options include surgery, radiosurgery and hearing preservations/restoration utilizing brainstem electrode implants at the time of tumour resection.

 

Haemangioblastoma

Haemangioblastomas are uncommon intracranial tumours accounting for 1–2% of all brain tumours and approximately 10% of posterior fossa tumours.

The haemangioblastoma arises from proliferation of endothelial cells. The tumour usually occurs in young adults, although it may occur at any age. It usually occurs in the posterior fossa and often produces a large cyst. Although haemangioblastoma may occur as a component of von Hippel–Lindau’s disease, which includes multiple haemangioblastomas, haemangioblastomas of the retina (von Hippel tumour), renal tumour, renal cyst, pancreatic cyst and tubular adenomata of the epididymis, the majority of patients with the cerebellar tumour do not have von Hippel–Lindau’s disease. Incomplete forms of the syndrome may occur and cerebellar haemangioblastomas occur in about 20% of patients with retinal haemangioblastoma.

The tumour presents as a slowly growing posterior fossa mass with features of raised intracranial pressure and cerebellar involvement. Occasionally the patient may be polycythaemic due to increased circulating erythropoietin. 

CT scan or MRI show a cerebellar tumour which may involve the vermis and hemispheres and which shows vivid enhancement following intravenous contrast. There is usually a low-density cyst surrounding the tumour nodule (Fig. 7.17), although haemangioblastomas may sometimes be solid. If considered necessary, vertebral angiography will confirm the highly vascular mass.

Total surgical excision through a posterior fossa craniotomy is nearly always possible. Great care must be taken not to enter the highly vascular tumour during the dissection and excision.

 

Colloid cyst of the 3rd ventricle

The colloid cyst of the 3rd ventricle is situated in the anterior part of the ventricle and is attached to the roof just behind the foramen of Monro. Several possibilities as to the origin of the tumour have been proposed, including the paraphysis, choroid plexus epithelium, ependyma or a diverticulum of the diencephalon.

The cyst consists of a thin, outer fibrous capsule lined by a layer of epithelium; the contents consist of mucoid material, epithelial debris and mucin. The cyst may be very small and asymptomatic. As the tumour grows it will cause bilateral obstruction to the foramina of Monro, leading to raised intracranial pressure from hydrocephalus. The headaches may fluctuate, being aggravated by stooping and relieved by standing upright. Episodes of abrupt, sudden leg weakness causing the patient to fall may occur without a change in conscious state. Alternatively, an abrupt loss of consciousness may occur and this, although usually transient, might be fatal.

The usual CT scan picture is a high-density, rounded tumour in the anterior 3rd ventricle which enhances following intravenous contrast (Fig. 7.18), although isodense, hypodense and non-enhancing tumours have been reported. MRI helps to define the position of these tumours (Fig. 7.18) and will be able to differentiate between a colloid cyst and an aneurysm of the basilar tip, which may occasionally be indistinguishable on CT scan.

Surgical excision is performed through a craniotomy with a small incision in the anterior corpus callosum giving access to the lateral ventricle. The tumour is seen expanding the foramen of Monro and, using the operating microscope, a complete excision is usually possible. Great care must be taken during the operation to preserve the venous structures, including the septal veins, thalamostriate vein and internal cerebral veins. Damage to the columns of the fornix will result in severe postoperativememory disturbance.

 

Epidermoid and dermoid cysts

Epidermoid and dermoid cysts arise from epithelial cells embryologically misplaced intracranially, particularly into the meninges and ventricles and, less frequently, into the parenchyma of the brain. Rarely, the cells can be implanted as a result of trauma such as a lumbar puncture, which can implant skin into the spinal canal causing an epidermoid cyst.

Epidermoid tumours are found principally in the arachnoid spaces, the cisterns or the diploe of the bone. The most frequent localizations are the cerebellopontine angle, the suprasellar and parasellar regions, the lateral or 4th ventricles, and the quadrigeminal cistern. Dermoid tumours occur mostly in the posterior fossa as a midline lesion and a fistula may connect the dermoid with the skin.

The epidermoid cyst contains desquamated epithelium surrounded by keratin-producing squamous epithelium. The dermoid cyst includes dermal elements such as hair follicles, sebaceous glands and sometimes sweat glands.

The cysts usually present following a long history of symptoms related to their position. Cranial nerve abnormalities such as trigeminal neuralgia and hemifacial spasm may occur with cerebellopontine angle epidermoid tumours and the suprasellar cyst will produce visual impairment with optic atrophy and often a bitemporal hemianopia. Leakage of epidermoid cyst contents may result in a chemical meningitis, and in patients with posterior fossa dermoid cysts, bacterial meningitis may occur through the dermal sinus connecting the cyst with the skin.

The CT scan of an epidermoid cyst is characterized by a low-density lesion that does not enhance. The dermoid cyst will also have areas which are even less dense than CSF, indicating the presence of fat (Fig. 7.19). MRI has superceded CT for accurate preoperative evaluation and planning. Epidermoid lesions are usually manifest as low signal on T1 and high signal on T2 images, although depending on lipid content, variable signal intensities may be seen within thesame lesion.

 

The treatment is operative, with resection of the cyst. Complete excision may be prevented if the cyst wall is densely adherent to major vessels and important neural structures.

PITUITARY ADENOMAS

 

Pituitary adenomas account for 8–10% of all intracranial tumours.

In 1886 Pierre Marie first made the connection between acromegaly and pituitary adenomas. Patients may present either with signs of endocrine disturbance or with compression of the adjacent neural structures, especially the optic pathways.

Classification

Historically, three main types of pituitary adenomas were defined by their cytoplasmic staining characteristics: chromophobic, acidophilic and basophilic—the implication being that these tumours were either hormonally inactive, secreted growth hormone, or produced adrenocorticotrophic hormone (ACTH), respectively.

The development of immunoperoxidase techniques and electron microscopy has provided a more refined classification of pituitary adenomas based on the specific hormone that is produced. This classification is shown in Table 8.1.

 

Pathology

Pituitary adenomas arise from the anterior lobe (adenohypophysis) of the pituitary gland which develops from Rathke’s pouch, an ectodermal diverticulum arising from the roof of the stomodeum, immediately in front of the buccopharyngeal membrane. The posterior lobe (neurohypophysis/pars nervosa) arises from the infundibulum developing from the floor of the diencephalon (Fig. 8.1).

The tumour arises within the pituitary fossa. If it is less than 10 mm in diameter it is known as a ‘microadenoma’. The tumour may grow locally within the sella and cause erosion and remodelling of the floor of the sella and posterior clinoid processes (macroadenoma). The tumour usually spreads superiorly into the suprasellar cisterns, where it may cause compression of the optic

pathways, particularly the optic chiasm. Further growth superiorly causes compression of the hypothalamus and, if large enough, obstruction of the 3rd ventricle, resulting in hydrocephalus (Figs 8.2).

 

The tumour may also grow laterally out of the sella into the cavernous sinus. Occasionally the lateral extension may be sufficient to cause disturbance of the cranial nerves in the cavernous sinus. Uncommonly the tumour penetrates further laterally, into the temporal lobe.

The tumour may infrequently extend inferiorly through the floor of the pituitary fossa into the sphenoid sinus, resulting in CSF rhinorrhoea.

The localization of microadenomas within the pituitary fossa corresponds somewhat with the regional distribution of the normal adenohypophyseal cells. Prolactin- and growth hormonesecreting microadenomas tend to occur laterally, whereas most adenomas secreting ACTH occur in the central zone.

Multiple endocrine neoplasia type 1 (Werner’s syndrome) is an autosomal dominant disorder representing the inherited occurrence of both benign and malignant neoplasms involving the pituitary gland, parathyroid gland and pancreas.

About 10% of pituitary adenomas are invasive, with extensive penetration of the pituitary capsule, dural sinuses and surrounding bone. Most invasive pituitary adenomas are sparsely granulated or chromophobic and are either hormonally inactive or prolactin producing. Metastasizing pituitary carcinoma, either extracranially or throughout the CSF pathway, is extremely rare.

 

Clinical presentation are due to:

• the size of the tumour

• endocrine disturbance.

Headache occurs principally in patients with macromegaly and is uncommon in other types of pituitary tumour.

Visual failure

Careful assessment of the visual fields, the visual acuity and the optic fundi is essential. Suprasellar extension of the pituitary tumour causes compression of the optic chiasm resulting in a bitemporal hemianopia. The bitemporal hemianopia initially involves the upper quadrants,before extending to the lower quadrants of  the visual field. If the chiasm is prefixed, that is, placed more anteriorly than usual, a homonymous hemianopia may occur due to compression of the optic tract. Bilateral central scotomas result from the tumour pressing on the posterior part of the chiasm where the macular fibres decussate. Primary optic atrophy will be evident in patients with long-standing compression of the chiasm. Ocular palsies occur in about 10% of patients and are due to invasion of the cavernous sinus. The 3rd nerve is the most frequently affected, followed by the 6th and 4th cranial nerves. Facial pain results from compression of the trigeminal nerve, usually the ophthalmic division, as a result of cavernous sinus invasion.

Endocrine abnormalities

Endocrine disturbance is due to either hypopituitarism or excess secretion of a particular pituitary hormone.

Hypopituitarism

Hypopituitarism results from failure of the hormones secreted by the adenohypophysis and it gives rise to the clinical features first described by Simmonds in 1914. Pituitary gland failure does not occur if the tumour is a microadenoma, but may be clinically evident in the larger tumours. The endocrine secretions are not equally depressed but there is a selective failure and the order of susceptibility is as follows: growth hormone, gonadotrophin, corticotrophin, thyroidstimulating hormone.

Gonadotrophic deficiency prior to puberty retards the development of secondary sex characteristics; adult men have poor beard growth, women suffer from amenorrhoea and both sexes have loss of libido and deficient pubic and axillary hair. The biochemical abnormality is manifest by a low oestrogen and androgen production with reduced urinary 17-ketosteroids. Hypopituitarism initially results in vague symptoms, including lack of energy, undue fatiguability, muscle weakness and anorexia and, when prolonged and severe, it will cause low blood pressure. Clinical hypothyroidism is manifest by physical and mental sluggishness and a preference for warmth. When the hypopituitarism is severe, episodic confusion occurs and the patient will become drowsy. It is essential to recognize the features of severe pituitary insufficiency as an endocrine crisis can be precipitated by minor stressful events occurring during hospital investigation or as a result of an intercurrent infection.

Pituitary apoplexy results from spontaneous haemorrhage into a pituitary tumour. It is characterized by sudden, severe headache followed by transient or more prolonged loss of consciousness with features of neck stiffness, vomiting and photophobia. The condition is similar to subarachnoid haemorrhage resulting from a ruptured aneurysm, but is often associated with paralysis of one or more of the ocular muscles (usually bilateral) and acute visual deterioration. An acute endocrine crisis may be precipitated by

the apoplexy.

Prolactinoma

The prolactin-secreting tumour may be a microadenoma or macroadenoma within the pituitary fossa. The patients are usually women who present with infertility associated with amenorrhoea and galactorrhoea, although the tumour may occasionally cause infertility in men. Large prolactinomas occur in the elderly and in males, and these can cause endocrine disturbance associated with hypopituitarism and visual failure.

Acromegaly

Acromegaly results from a growth hormonesecreting pituitary adenoma which, as described previously, consists of cells that stain either as acidophils, chromophobes or both. The onset of acromegaly is slow and insidious, usually during the 3rd and 4th decades of life, with both sexes being affected equally. The clinical features (Table 8.3) include bone and soft tissue changes that are evident as an enlarged supraciliary ridge, enlarged frontal sinuses and increased mandibular size, which will cause the chin to project (prognathism) (Fig. 8.6). The hands and feet enlarge, and the skin becomes coarse and greasy and sweats profusely. The voice becomes hoarse and gruff and thoracic kyphosis occurs as a result of osteoporosis. Other problems associated with acromegaly include hypertension, cardiac hypertrophy and diabetes. Headache is often severe in patients with pituitary tumours causing acromegaly and patients complain of lack of energy, physical weakness and lassitude. Suprasellar extension of the tumour occurs in about 15% of cases and may result in compression of the optic pathways.

A pituitary adenoma with excessive growth hormone secretion occasionally presents in childhood and results in gigantism.

Cushing’s disease

Cushing’s disease is due to ACTH-producing pituitary adenomas. Over 80% of the tumours are microadenomas and the remainder are macroadenomas involving the whole of the sella or with extrasellar extension. The onset is insidious and the disease may affect children or adults. Severe obesity occurs, the skin is tense and painful, and purple striae appear around the trunk. Fat is deposited, particularly on the face (moon face), neck, cervicodorsal junction (buffalo hump) and trunk. The skin becomes a purple colour due to vasodilatation and stasis. Spontaneous bruising is common. The skin is greasy, acne is common and facial hair excessive. Patients complain of excessive fatigue and weakness. There is wasting and flaccidity of the muscles. Osteoporosis predisposes to spontaneous fractures.

Glucose tolerance is impaired, the serum potassium is low and vascular hypertension occurs. If untreated, 50% of cases are fatal in 5 years.

 

Laboratory investigations

Radioimmunoassay will help to identify the hormone being secreted.

Serum prolactin level in patients with prolactinomas will vary from just above the upper limit of normal to values greater than 20 000 mIU/l (normal 70–550 mIU/l). The levels may show considerable variation in a particular patient and prolactin levels greater than 2000 mIU/l are almost always indicative of a pituitary tumour. As mentioned previously, hyperprolactinaemia may be associated with other pituitary tumours and has been noted in some patients with acromegaly. Null cell tumours may be associated with mild hyperprolactinaemia due to distortion of the pituitary stalk or impingement on the hypothalamus.

Serum growth hormone is measured by radioimmunoassay, the normal values being less than 5 mIU/l in males and less than 10 mIU/l in females. Growth hormone exerts its effects on peripheraltissues indirectly via somatomedins—polypeptides produced primarily by the liver and fibroblasts. Serum somatomedin C (insulinlike growth factor I, IGF-I) is a more accurate indicator of growth hormone bioactivity than the serum growth hormone levels. Provocative tests of growth hormone secretion are useful in confirming acromegaly. Most patients with  acromegaly do not show the normal suppression of growth hormone following glucose load.

Other provocative tests utilize thyrotrophinreleasing hormone and growth hormonereleasing hormone.

In contrast to other pituitary tumours that rely on imaging studies as the foremost diagnostic investigation, a careful endocrinological assessment is critical in the diagnosis of Cushing’s disease, especially as in nearly 50% a tumour is not evident on MRI.

There are three essential steps in the diagnosis of Cushing’s disease due to pituitary pathology.

1 Confirm excess secretion of cortisol (normal 120–650 nmol/l).

2 Distinguish ACTH-dependent from ACTH-independent causes of hypercortisolaemia.

3 Distinguish pituitary-based Cushing’s disease from ectopic states of ACTH production.

A24-hour urine specimen is the simplest initial means of establishing hypercortisolaemia.

The investigation of Cushing’s disease involves the measurement of ACTH by radioimmunoassay of samples of both peripheral blood and blood from the petrosal sinus. A differential level of ACTH in petrosal vein blood and peripheral blood will help confirm the presence of a pituitary basis for the ACTH production, especially after administration of corticotrophin-releasing hormone (CRH). A dexamethasone suppression test will help diagnose Cushing’s syndrome and its cause. The urine- and plasma-free cortisol is measured and is normally suppressed following administration of low-dose dexamethasone (0.5 mg 6-hourly). The levels will be suppressed following high-dose dexamethasone (2mg 6-hourly) in pituitary-dependent Cushing’s disease. There will be a failure of suppression of the levels with high-dose dexamethasone if the Cushing’s syndrome is due to other than pituitary causes.

Radiological investigations

High-resolution CT scanning and magnetic resonance imaging using thin slices and intravenous contrast are the appropriate investigation. Pituitary microadenomas are usually hypodense and may cause upward bulging and convexity of the upper border of the gland in adults, deviation of the pituitary stalk and thinning of the sellar floor on the side of the tumour. High-quality CT scanning is able to demonstrate tumours as small as 4 mm in diameter. Macroadenomas enhance after intravenous contrast and the exact nature of the extrasellar extension can be best appreciated with direct coronal scans (Fig. 8.8). 

MRI has improved the identification of microadenomas, which appear as low-density focal lesions on T1-weighted scans and high intensity on T2-weighted scans (Fig. 8.9). Macroadenomas usually appear as isointense on the T1-weighted images and moderately hyperintense on the T2- images. Haemorrhage into a tumour, such as occurs following pituitary apoplexy, shows as high-intensity areas because of methaemoglobin on the T1- and T2-weighted scans intermingled with low-density regions due to haemosiderin (see Figs 8.5 and 8.9). Dynamic scans taken at 30-second intervals following intravenous gadolinium may help demonstrate small microadenomas. 

Plain skull X-rays may show enlargement of the sella with thinning erosion or bulging of its contours (Fig. 8.11).

In the past angiography has been performed to exclude incidental aneurysms and to determine the position of the internal carotid arteries in the cavernous sinuses, but this information can now be obtained satisfactorily from good-quality MRI and, if necessary, magnetic resonance angiography. 

Differential diagnosis

The major differential diagnoses are:

• craniopharyngioma

• suprasellar meningioma (arising from the tuberculum sellae).

Uncommon masses around the suprasellar region also include optic nerve and hypothalamic glioma, giant aneurysm arising from the carotid artery, Rathke’s cleft cysts, suprasellar germinomas and chordomas.

Treatment

The objectives of treatment of patients with pituitary tumours depend on whether the patient has presented with features of endocrine disturbance or problems related to compression of adjacent neural structures. The methods of treatment used are:

1 Operative procedures:

(a) transsphenoidal excision

(b) transcranial excision.

2 Radiotherapy.

3 Medical treatment with antisecretory drugs.

Surgical excision

This will be used as the primary method of treatment for:

• large tumours causing compression of adjacent adjacent neural structures, particularly the visual pathways

• GH-secreting tumours causing acromegaly

• ACTH-secreting tumours causing Cushing’s disease

• the occasional treatment of a prolactin-secreting adenoma, either microadenoma or macroadenoma confined within the sella, when medical treatment using bromocriptine is not tolerated.

Most tumours can be excised via the transsphenoidal approach to the pituitary fossa

The development of the surgical microscope and fluoroscopic radiography has made this a safe procedure. The sphenoid sinus is usually entered using a unilateral trans-septal approach, with the incision either in the nasal mucosa or sublabially. The mucosa is reflected from the nasal septum and floor and the sphenoid is opened. The anterior wall of the sella is removed and the pituitary fossa entered. Microadenomas (tumours less than 10mm in diameter) may be evident on the surface of the gland or may become evident only once the gland is incised. These tumours can be completely excised, preserving pituitary function. The suprasellar extension of the tumour can be gently coaxed down into the pituitary fossa by slightly raising the intracranial pressure using a Valsalva manoeuvre or by the anaesthetist injecting small increments of nitrous oxide and oxygen mixture into the lumbar theca until the intracranial pressure forces the suprasellar tumour into the operative field. This will also have the additional benefit that the intracranial gas will provide a pneumoencephalogram, outlining the remaining suprasellar extension of tumour.

A transcranial operation is occasionally necessary, particularly where there is a subfrontal or retroclival extension of the tumour.

Postoperative management requires careful attention to the fluid balance and hormonal status. Endocrine deficiency in the immediate postoperative period will require replacement with parenteral hydrocortisone and possibly the use of vasopressin for the treatment of diabetes insipidus, which often occurs at least transiently after the excision of a large pituitary tumour. In the early postoperative period aqueous vaso-pressin (Pitressin ®) should be given by intramuscular or subcutaneous injection and, if the diabetes insipidus persists, by the intranasal route. Other long-term hormonal replacements may include cortisone acetate (12.5–25 mg twice daily), thyroxine and testosterone.

Radiotherapy

Postoperative radiotherapy may be used if there has been a subtotal excision of the tumour or if the postoperative endocrine studies demonstrate residual excessive hormone secretion.

Medical treatment

Treatment of pituitary adenomas is undertaken to restore the endocrine status of the patient by replacement of either the pituitary hormone itself or the hormone of the pituitary-dependent glands. This will be a necessary preoperative procedure in patients with evidence of hypopituitarism and will frequently be necessary after the surgical excision of a macroadenoma. Prolactin-secreting pituitary tumours are treated with bromocriptine, a dopamine agonist. This is the preferred treatment for a symptomatic prolactin- secreting microadenoma and may be used either as the definitive treatment of larger prolactin- secreting tumours or in conjunction with surgery. Some patients show poor tolerance to bromocriptine, as it may cause intractable nausea, vomiting and postural hypotension, and these patients will require surgical treatment of the tumour.

Craniopharyngioma

This tumour may occur at any age, although nearly half occur in the first 20 years of life. They are thought to arise from the epithelial remnants of Rathke’s pouch. The tumours occur in the region of the pituitary fossa and extend through the suprasellar cisterns to the hypothalamus. There are two histological types of tumours. The adamantinous type resembles adamantinoma of the jaw and is encountered in virtually all children. The papillary type, so-called adult craniopharyngioma, occurs in about one-third of adults and is rare in children.

Clinical presentation

Clinical features include:

• raised intracranial pressure

• visual impairment

• endocrine dysfunction.

Raised intracranial pressure

This is common, particularly in children, who present with headache, vomiting and papilloedema.

Visual impairment

This is due to papilloedema, chiasmal compression or a combination of both. Papilloedema is due to hydrocephalus as a result of 3rd ventricular obstruction by the tumour. The visual field defect is frequently similar to that produced by a pituitary tumour, a bitemporal hemianopia, but homonymous defects are more common than in pituitary adenoma.

Endocrine abnormalities

These are frequent in children and consist of:

• hypogonadism

• stunting of growth

• diabetes insipidus.

Endocrine failure due to craniopharyngioma arising in adults is essentially similar to that caused by a pituitary tumour, except that diabetes insipidus occurs more commonly in patients presenting with craniopharyngioma.

Investigations

The CT scan usually shows a cystic tumour in the suprasellar region with calcification (Fig. 8.14). Tumours in adults may be solid and are less calcified than those seen in younger patients. MRI is useful in showing the full extent of the tumour (Fig. 8.15). Changes in the sella turcica are seen in approximately 50% of patients. Suprasellar tumours and the associated hydrocephalus press downwards on the dorsum sellae and anterior clinoids and may enlarge the sella. Nearly 90% of tumours in children have radiographically identifiable calcification in the tumour, whereas only 40% of adults have radiologically demonstrable calcification. The calcification consists of aggregates of small flecks of calcium and may be curvilinear, outlining a portion of the cyst wall. 

Treatment

Preoperative visual and endocrine assessment is essential. The standard treatment for craniopharyngioma is operative, with an attempt at maximal resection of the tumour. However, complete resection may not be possible due to the extent of the tumour and the intimate attachment to hypothalamic vital structures. The usual surgical approach is through a pterional craniotomy or a bifrontal craniotomy with separation of the frontal lobes and division of the lamina terminalis. Tumours extending into the 3rd ventricle may also need to be approached through the corpus callosum. An extended transsphenoidal approach is sometimes advised for those tumours extending down to the floor of the pituitary fossa.

Postoperative management will include careful attention to fluid and electrolyte balance as many patients have at least a transient diabetes insipidus following surgery. Other hormones may need replacement depending on endocrinological assessment.

The role of postoperative radiotherapy in patients with a subtotal resection is controversial but radiotherapy may be beneficial in decreasing the production of cyst fluid and delaying recurrence of the tumour.

Empty sella syndrome

The empty sella refers to a communicating extension of the subarachnoid space into the pituitary fossa. This may occur as a result of an incomplete anatomical formation of the diaphragma sellae which allows the arachnoid to herniate directly into the pituitary fossa or as a secondary phenomenon following either pituitary There is good reason to regard the empty sella as an anatomical variant rather than a syndrome. However, defects in the diaphragma are not the only requirement for formation of an empty sella. Increased intracranial pressure associated with benign intracranial hypertension or long-standing hydrocephalus will cause herniation of the subarachnoid space into the sella and will result in the remodelling of the pituitary fossa to produce the classic globular appearance on plain X-ray and CT scan (Fig. 8.18). It is possible that the normal variations in CSF pressure may be transmitted into the fossa through an incompetent diaphragma and so result in the bony changes.

Clinical presentation

Most patients with the radiological features of an empty sella are asymptomatic. The majority of patients presenting with symptoms are obese, middle-aged, hypertensive women. Headache is the most common symptom associated with the empty sella but the features are so varied that their relevance to the intrasellar subarachnoid space is dubious without an underlying cause for possible raised intracranial pressure. Visual field defects and endocrine abnormalities are subtle and uncommon in patients with primary empty sella syndrome. In patients with a secondary empty sella, e.g. following surgery or radiotherapy, field defects may be more pronounced but are rarely severe.

The most serious consequence of an empty sella is spontaneous CSF rhinorrhoea. This usually occurs only if there has been an underlying cause of raised intracranial pressure, such as benign intracranial hypertension. It is managed by repairing the leak in the floor of the sella with crushed muscle and fascia lata and performing a CSF shunt.